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Abstract
Introduction: Ulceration is defined as a breakdown of the skin. The treament of ulcers
can be difficult and both time and cost expensive for the patient and health service.
Determining what has caused this ulceration and formulating a treatment plan is key.
There is no one universally accepted test which can accurately predict if a wound will
heal or what treatment will be successful in healing it. Assessing the peripheral arterial
system is an important first test to ensure that there is adequate blood perfusion to the
ulcerated area. This is carried out by performing a test called Toe Brachial Indices
(TBI’s).
In 2012 a new test called transcutaneous oximetry (tcpO2) was introduced to the
vascular laboratory service in a bid to gain extra information on ulcer diagnosis and
potential healing status. This test examines tissue oxygenation levels at a particular site.
The purpose of this audit is to determine if tcpO2 provides any additional diagnostic
information.
Method: From its introduction in 2012 and for the following three years all results of
this test and a set of TBI’s were audited. Patients who presented to the vascular service
with an active foot ucleration had both tests performed. A medical history was taken to
record the risk factors of peripheral arterial disease.
Results: There were a total of 247 patients included in the audit which equated to 310
tests for anaylsis (a number of patients had tests performed on both feet). The age range
was 32 – 94 years old with a mean age of 67.5 years and a median age of 69 years. Both
tests were compared. tcpO2 and TBI’S were statistically lower in the smokers in
comparision to the non smokers. Absolute toe pressures were statistically lower in the
patients on statins and antihypertensives when compared to those not. Nether of these
areas are well researched. When all test results were compared 70% of tests had reduced
TBI results indicating arterial disease. Of this 70%, 39% had a tcpO2 result which was
below a normal threshold suggestive that spontaneous healing was not likely to occur.
This group with low TBI’s and low tcpO2 had significant numbers of interventions and
amputations. More interestingly, the remaining 31% of tests had a tcpO2 test outcome
which was above the normal threshold suggestive of spontaneous healing. These tests
required a lower number of interventions and amputations when compared to the tests
where both results are normal.

V

Conclusion: In the setting of peripheral arterial disease the addition of tcpO2 does
provide additional further diagnostic information that should be taken into
consideration with a TBI result when treating foot ulceration. In the absence of a TBI
result it is reasonable to consider a tcpO2 test as an alternative source of diagnostic
information.
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Chapter 1

Introduction
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Introduction
The human foot is a highly complex structure and any problems it develops can result
in a deterioration of a patients overall health and hence quality of life. There are various
diseases, both of the foot and within the body, that lead to foot problems. Ulceration is
one such problem. Ulceration is where an area of skin, which for whatever reason, has
broken down and one can see the underlying tissue. Often in many cases the skin heals
quickly, but unfortunately there are some cases where certain disorders or physiological
conditions can impede the body’s normal healing process.

One particular metabolic disorder that can prevent a quick healing process is diabetes
mellitus. Foot ulceration is more common in patients with diabetes because they can
develop a number of complications which are discussed in chapter 2, section 2.0. These
complications can lead to minor problems such as small cuts, blisters, bruises etc. going
undetected which can very quickly become worse and develop into ulceration. The
complexity of ulceration can be troublesome and doctors look to many disciplines such
as dermatology, podiatry, endocrinology and vascular diagnostics when treating them
in the hope of aiding a positive outcome.

Indeed there have been many advances in recent years in terms of both vascular surgery
techniques and investigative techniques to evaluate lower limb perfusion. These are in
a bid to help improve perfusion, where it is an obstacle to wound healing. Despite these
advances there is still no one universally accepted test that can predict wound healing,
as it is globally accepted that it is dependent on a number of factors both local and
systemic. General consensus would be that it is unlikely that one test will ever achieve
100% accuracy. And so, with this in mind the aim of this thesis is to analyse the results
of a new test introduced into our vascular laboratory service – Transcutaneous
Oximetry (tcpO2) and to determine if it aids the treatment of patients with active foot
ulceration and whether it provides any additional or alternative diagnostic information
which alters the outcome or treatment of foot ulceration? Any additional supports this
new and non-invasive test can provide to assist in the decision making of treatment
planning will be quantified. A total of 247 patients were audited from December 2012
– December 2015. These equated to 310 initial tcpO2 tests with a corresponding TBI
test. The cost associated with managing and treating a chronic foot ulceration places a
2

significant strain on the health service and one that is going to increase with the
increasing number of diabetic diagnoses. Cases of diabetes have progressively
increased worldwide and it has been noted that there has been a two fold increase in the
numbers of adults with diabetes in recent years. (Danaei et al. 2011). With the
combination of the excessive costs in treating diabetic foot ulceration, combined with
the detrimental effects they have on the patients overall health status, it is becoming
increasingly necessary to develop and implement new methods to predict wound
healing in this patient cohort.

3

Chapter 2

Diabetes Mellitus and lower limb
arterial disease

4

Background
2.0 Diabetes Mellitus – what is it?
Diabetes mellitus is a common but chronic condition which causes significant
morbidity and mortality if it is not properly diagnosed and managed. It is defined as a
group of metabolic disorders which are characterised by too much glucose in the blood,
also called hyperglycaemia. The digestive tract breaks down carbohydrates – sugars
and starches found in food – into glucose which is a form of sugar that enters the
bloodstream. The hormone insulin (made in the pancreas) allows the body to then use
that sugar by helping glucose to enter the cells where it can be absorbed and used for
energy. The pancreas is located behind the stomach and contains clusters of cells called
islets. It is the beta cells within these islets that make insulin and are responsible for its
release into the blood.

Figure 2.1 Islets within the pancreas containing beta cells
When a person has diabetes, either the pancreas fails to produce enough insulin or the
body cannot properly use the insulin it has. As a result there is a build-up of glucose in
the blood causing the cells to be starved of energy.

5

2.0.1 Types of diabetes
There are two types of diabetes:
Type 1:
Type 1 diabetes (previously known as insulin dependent, juvenile or childhood onset)
is characterised by a lack or deficiency of insulin in the body (World Health
Organization 1999). Normally the immune system protects the body from infection by
identifying and destroying bacteria, viruses and other potentially harmful foreign
substances. Type 1 diabetes occurs due to an autoimmune disease, where the body’s
immune system attacks and destroys its own cells, which in the case of Type 1 diabetes
is the insulin producing beta cells in the pancreas. Treatment requires the daily
administration of insulin (National Institute of Diabetes and Digestive and Kidney
Diseases 2016). This type of diabetes occurs most frequently in children, with its cause
not known or preventable to date. Symptoms include excessive urination, thirst,
constant hunger, weight loss, vision changes and fatigue. Symptom onset may occur
suddenly.
Type 2
Type 2 diabetes (previously known as non-insulin-dependent or adult onset) is the most
common form of diabetes and is caused by a combination of factors which include
insulin resistance. This is a condition in which the body’s muscle, fat and liver cells do
not use insulin effectively. It develops when the body can no longer produce enough
insulin to compensate for the impaired ability to use insulin (National Institute of
Diabetes and Digestive and Kidney Diseases 2016). It is largely the result of excess
body weight and a lack of physical activity. This type is estimated to affect up to 95
percent of people with the condition. Symptoms may be similar to those of Type 1
diabetes but are often less marked (Irish Health 2003). This type of diabetes was most
commonly diagnosed in patients aged 40 or older but it is starting to emerge in the
population at a younger age (Chronic Conditions Hub 2016).
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Gestational diabetes is hyperglycaemia with blood glucose values above normal but
below those diagnostic of diabetes and occurs during pregnancy. Women with
gestational diabetes are at an increased risk of complications during pregnancy and at
delivery. This type of diabetes is diagnosed through prenatal screening (Diagnostic
criteria and classification of hyperglycaemia first detected in pregnancy (World Health
Organization 2013).

2.0.2 Consequences of diabetes
Diabetes places a significant burden of care on the individual, the health care
professionals and the wider health system (Zimmet et al. 2001). Individuals with it,
over time, can develop problems with many parts of the body including the heart, the
blood vessels, the eyes, the kidneys and even the nerves. The following is a list of the
most common side effects:


A combination of reduced blood flow and nerve damage (neuropathy, section
2.1) in the feet increases the chance of foot ulceration, infection and perhaps
even lead to eventual amputation (Emerging Risk Factors et al. 2010).



Adults with diabetes have a 2-3 fold increased risk of heart attacks and strokes
(Emerging Risk Factors et al. 2010)



Diabetic retinopathy is an important cause of blindness and occurs as a result of
long term damage to the small blood vessels in the retina (Bourne et al. 2013).



Diabetes is among the leading cause of renal failure (National Institute of
Diabetes and Digestive and Kidney Diseases 2014).

2.0.3 Prevalence of diabetes
In Ireland, there is no diabetes register or surveillance programme and so estimates of
prevalence vary. The Institute of Public Health have commissioned a number of reports
in recent years looking at the prevalence of diabetes in Ireland. “Making Diabetes
Count” 2005, “Making Diabetes Count 2007” and “Making Chronic Conditions count
2010 have all shown increasing rises in the number of diagnosed diabetics in the
Republic of Ireland (Balanda et al. 2010, The Institute of Public Health 2006, The
Institute of Public Health 2007). Prevalence of the disease has reached all estimated
targets set out in these reports. It is important to also note, that there are numerous
7

people undiagnosed with the disease. According to the International Diabetes
Federation (IDF) Diabetes Atlas, sixth edition, there are approx. 70,610 undiagnosed
cases in Ireland (International Diabetes Federation 2015).
Diabetes Ireland estimate that during 2011 the number of people, of all age groups, with
diabetes in Ireland (Type 1 and Type 2 populations combined) reached 191,000
(Diabetes Ireland 2016).
Currently Diabetes Ireland states that, the IDF Diabetes Atlas (2013) estimate that there
are 207,490 people with diabetes in Ireland in the 20 – 79 age group (a prevalence of
6.5% in the population). This is in line with previous estimates that by 2020 there would
be 233,000 people with the condition, and by 2030 there would be 278,850 people with
the condition (a prevalence of 7.5% in the population) (International Diabetes
Federation 2013) in Ireland.
Worldwide statistics say one in twelve of the world population have diabetes which
equates to approx. 387 million people with a prevalence of 8.3%. This is expected to
increase by 205 million by 2035. It is also suggested that one in two don’t know they
have diabetes and remain undiagnosed. Every six seconds one person dies from diabetes
and there were 4.9 million deaths in 2014 directly attributed to the disease (International
Diabetes Federation 2013).

2.0.4 Economic cost of diabetes
Diabetes can cause a variety of health complications for patients. It is responsible for
many early deaths, reduced quality of life and significant costs to the health and social
care system as well as the overall economy. The life expectancy of people with diabetes
is shortened by up to 15 years, and 75% die of macrovascular complications (National
Institute for Health Care Excellence 2016b).
It is estimated that 10% of all people with diabetes will have a diabetic foot ulcer at
some point in their lives. Diabetes is the most common cause of non-traumatic limb
amputation, with diabetic foot ulcers preceding more than 80% of amputations in
people with diabetes. After a first amputation, people with diabetes are twice as likely
to have a subsequent amputation as people without diabetes. Mortality rates after
diabetic foot ulceration and amputation are high, with up to 70% of people dying within
8

5 years of having an amputation and around 50% dying within 5 years of developing a
diabetic foot ulcer (National Institute for Health Care Excellence 2016b).
The budget for the Irish health service in 2014 was €12.774 billion. For 2015 there was
an increase of Exchequer funding of €305 million, bringing the budget up to €13.079
billion (Department of Health 2014). It is estimated that approx. In Ireland 10% of the
total health budget is spent on diabetes - approx. €1.27 billion with a further estimate
of 60% of this being spent annually on complications which includes foot ulcers (Nolan
et al. 2006). The increasing economic burden of diabetes on our health care system is
becoming a major challenge for the government.

9

2.1

Diabetes and the foot

Foot ulcers can be complex and difficult to manage. The ever increasing diabetic group
are the most complex and difficult patient cohort to manage when it comes to wounds
and ulceration.
Patients with diabetes run an increased risk of developing foot problems largely because
of either diabetic neuropathy or narrowing of the arteries called peripheral arterial
disease (PAD).
PAD leads to a reduction in perfusion to the foot which in turn often leads to skin
breakdown – see arterial ulceration, section 2.2. PAD affects 1 in 3 people with diabetes
over the age of 50 (National Institute for Health Care Excellence 2016b).
In patients with diabetes, they can often have a higher than normal blood sugar level so
that over time nerves can become damaged (National Institute of Diabetes and
Digestive and Kidney Diseases 2013).The increased blood sugar interferes with the
ability of the nerves to transmit signals. Diabetes also weakens the walls of the small
blood vessels (capillaries) that supply the nerves with oxygen and nutrients. This
damage leads to a loss of sensation in the peripheries (hands and feet), and an inability
to feel pain which is called peripheral or diabetic neuropathy. Peripheral neuropathy
can also cause muscle weakness and hence a loss of reflexes, especially at the ankle,
which can lead to changes in the way a patient walks. Foot deformities are common.
Some patients have mild symptoms but for others they can be disabling and even fatal.
Often symptoms develop gradually, and the patient may not notice problems until
considerable damage has occurred. What can start out as a small cut, if it goes
unnoticed, can eventually end up becoming severely infected. The risk of infection is
high in this patient group, and if it develops to affect the bone, it can lead to tissue death
(gangrene). In this case ulcers become impossible to treat and require amputation of a
toe, foot or even the lower leg. From the above, it is easy to understand why people
with diabetes are more prone to foot ulcers than other patient groups. Early detection
of foot and skin sores is vital to help prevent infection and progression into full blown
ulceration.
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2.2

Ulceration

The skin is tough, pliable and resistant to injury. In the case of it becoming injured or
broken, it is generally very resilient and has an amazing ability to self-repair and heal.
Despite this resiliency, the skin is unfortunately susceptible to breakdown if subjected
to prolonged abuses such as excessive pressure, shear force, friction or moisture. Skin
breakdown ranges from minor scrapes, cuts, tears, blisters or burns to the most serious
pressure ulcers, with the destruction of tissue down to and even including the bone.
Ulcers are wounds, open sores or simply a break in the skin that allow air and bacteria
to get into the underlying tissue. They are a direct result of damage or destruction of
the epidermis or dermis which can allow infection to manifest. This in turn can often
lead to the wound not healing or for the wound to keep returning frequently.

A

B

Figure 2.2 A & B Diabetic foot ulceration
In most people, small wounds or injuries heal up quickly and without any difficulty
within a week or two. If there is an underlying problem, the skin does not heal and the
area of breakdown can actually increase in size. This then becomes a chronic ulcer.
There are many contributing factors for ulcer development including poor nutrition and
hydration, weight, impaired circulation and oxygenation, substance abuse, depression,
and age. Smoking, diabetes and other vascular conditions can lead to decreased
circulation which increases the risk for skin breakdown. Diabetes is a leading
underlying contributory factor. Chronic and non-healing wounds are problematic not
only for the patient but also for the health care system. They can often lead to long
hospitalisation periods due to slow healing. The complex diabetic patient group, with
11

their many risk factors affecting their ability to heal ulcers, can lead to a very lengthy
and also very costly process for both the patient and health service. Research and health
initiatives have been developing around foot protection and specifically in the
prevention of problems rather that the treatment of them.
One of the most important issues when it comes to ulcers is determining the cause and
then ensuring the area is receiving enough nutrients to encourage and promote healing.
Arterial disease accounts for approx. 15% of all leg ulcers with the remaining causes
being venous disease (approx. 80%) with other causes such as diabetes, rheumatoid
arthritis, malignancies and lymphoedema accounting for approx. 5% (Circulation
Foundation 2016). In some cases two or more conditions can be attributed to the cause
of the ulcer and hence to treat effectively it is important to diagnose at an early stage
the type of ulcer present. Arterial ulceration and diabetes go hand in hand and so will
be further discussed.

12

2.2.1 Atherosclerosis and arterial ulcers:
Atherosclerosis is a systemic disease which affects the arteries. Fatty deposits called
atheroma build up on the inside lining of the arteries which reduces the lumen of a
vessel thus reducing the blood flow through the vessel.

Figure 2.3 Normal versus a diseased artery

A reduction in blood flow to various parts, in turn leads to a decreased oxygen supply
to the tissue being supplied by that vessel. Arteries in the legs are commonly affected
which in turn leads to poor perfusion of the feet.

What causes atherosclerosis? The most commonly recognised risk factors in the
development

of

atherosclerosis

are

smoking,

diabetes,

hypertension,

hypercholesterolemia, lack of physical activity, family history, obesity and gender
(National Institute of Health 2016).
The restriction of blood flow to the legs and feet due to the build-up of atheroma on the
arteries is called peripheral arterial disease (PAD). PAD can vary from mild to severe
and it is important to assess prior to treating any patients presenting with ulceration.
Patients with ulceration who have been diagnosed with severe PAD or critical lower
limb ischaemia may progress to major limb loss unless successful surgical intervention
13

occurs. Blood pressure measurements are used to produce an index which indicates a
percentage of blood flow to the area being examined. The baseline tests for patients
suffering with PAD and/or ulceration is Ankle Brachial Indices (ABI’s) or Toe Brachial
Indices (TBI’s). TBI’s are the standard test of choice in the diabetic patient group. Often
in the diabetic patient group the tibial vessels are affected by calcification causing them
to be falsely elevated or incompressible and so TBI’s are deemed to be more reliable as
a marker of perfusion. This test is detailed in chapter 5, section 5.3.2.

Work done by others has shown that in the diabetic patient group the risk of
atherosclerotic disease is markedly increased. It is also noted that it can develop at an
earlier age, be more severe and more diffuse making it very difficult to treat
successfully (Marso S. P. Hiatt W. R. 2006).
The measurement of TBI’s is a reproducible and quantitative test to assess arterial blood
flow to the lower extremities. It is non-invasive and can diagnose the presence of PAD
and determine its severity.

14

Chapter 3

Lower limb arterial anatomy

15

Anatomy
3.1

Anatomy of the human skin

The skin is a vital organ that covers the entire outside of the body making it the body’s
largest organ. It receives one third of the body’s blood circulation. It is comprised of
two layers that cover a third fatty layer. These three layers differ in their function,
thickness, and strength. The outer layer is called the epidermis - it is a tough protective
layer that contains the melanin-producing melanocytes. The second layer (located
under the epidermis) is called the dermis - it contains nerve endings, sweat glands, oil
glands, and hair follicles. Under these two skin layers is the fatty layer of subcutaneous
tissue, known as the subcutis or the hypodermis.

Figure 3.1 Diagram of the skin
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1) The Epidermis
This is the outermost layer of the skin. The thickness of the epidermis varies in different
types or location of skin. Its role is to form a protective barrier against pathogens and
various injuries that could occur due to the environment. It shields the body against
heat, light, injury, and infection. It also helps regulate body temperature, gathers
sensory information from the environment, stores water, fat, and vitamin D, and plays
a role in the immune system protecting us from disease.
The epidermis itself is made up of five sub-layers that work together to continually
rebuild the surface of the skin.
The five sub-layers are as follows:
i) The Basal Cell Layer
This contains small round cells called basal cells which continually divide, with
new cells constantly pushing older ones up towards the surface of the skin, where
they are eventually shed. The basal cell layer contains cells called melanocytes
which give the skin its colouring or pigment known as melanin. These also protect
the deeper layers of the skin from the harmful effects of the sun.

ii) The Squamous Cell Layer
This is located above the basal layer. The basal cells that have been pushed upward,
are maturing and become known as keratinocytes. These produce keratin, which is
a tough, protective protein that makes up the majority of the structure of the skin,
hair, and nails. This is the thickest layer of the epidermis.

iii & iv) The Stratum Granulosum & the Stratum Lucidum
The keratinocytes from the squamous layer are then pushed up through these two
thin layers. As these cells move further towards the surface of the skin, they get
bigger and flatter and adhere together, and then eventually become dehydrated and
die. This process results in the cells fusing together into layers of tough, durable
material, which continue to migrate up to the surface of the skin.
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v) The Stratum Corneum
This is the outermost layer of the epidermis, and is made up of 10 to 30 thin layers
of continually shedding, dead keratinocytes. As the outermost cells age and wear
down, they are replaced by new layers of strong, long-wearing cells.

2) The Dermis
The dermis is located beneath the epidermis and is the thickest of the three layers of the
skin and makes up approximately 90 percent of the thickness of the skin. Its main
function is to regulate temperature and to supply the epidermis with nutrient-saturated
blood. The dermis layer is made up of two sub-layers. One is called the Papillary Layer
which supplies nutrients to the epidermis and regulates temperature and the other is the
Reticular Layer which strengthens the skin, to provide structure and elasticity.
Much of the body's water supply is stored within the dermis. This layer contains most
of the skins specialised cells and structures, including:


Blood vessels which supply nutrients and oxygen to the skin and take away cell
waste and cell products



Lymph cells or capillaries are a network of tiny walled vessels which pick up
fluid that leaks into the tissue from the blood stream and which is returned back
to the circulatory system.



Hair follicles are a tube-shaped sheath that surrounds the part of the hair that is
under the skin and nourishes the hair



Sweat glands which in the armpits and pubic region secrete a milky sweat that
encourages the growth of the bacteria responsible for body odour. Other glands
over the body regulate body temperature by bringing water via the pores to the
surface of the skin, where it evaporates and reduces skin temperature.



Sebaceous glands secrete oil that helps keep the skin smooth and also helps
keep skin waterproof and protects against an overgrowth of bacteria and fungi
on the skin.



Nerve endings are pain and touch receptors that transmit sensations of pain,
itch, pressure and information regarding temperature to the brain for
interpretation
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Collagen is a protein made by fibroblasts that is found throughout the body in
the connective tissues that hold muscles and organs in place.



Elastin, a similar protein that allows the skin to spring back into place when
stretched and keeps the skin flexible.

3) The Subcutis
This is the innermost layer of the skin. It consists of a network of fat and collagen cells.
It functions as both an insulator, conserving the body's heat and as a shock-absorber,
protecting the inner organs. It also stores fat as an energy reserve for the body. The
blood vessels, nerves, lymph vessels, and hair follicles also cross through this layer.
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3.2

The Macrocirculation

The macrocirculation is the circulation of blood through the larger vessels in the body
- arteries and veins. The following section will detail the anatomy of the lower limb
arteries.

3.2.1 Anatomy of arteries
Arteries are blood vessels within the body whose main function is to deliver oxygenrich blood from the heart to the various organs and tissues of the body. Arteries, despite
their location in the body, have a similar structure. Each artery is a muscular tube lined
by smooth tissue with three distinct layers:


The intima

The intima is the inner layer which is lined by a smooth tissue called endothelium. This
is composed of a thin layer of endothelial cells and lines the entire circulatory system
from your heart to the large arteries, right all the way down to the very tiny capillary
beds.


The media

The media is composed of a smooth layer of muscle fibres surrounded by fibrous tissue
which allows the arteries withstand the high pressures from the heart. This muscular
layer permits the arteries to constrict and dilate to adjust the volume of blood needed
by the tissues that they feed.


The adventitia

The adventitia is the outermost layer and it is used to attach the vessel to the surrounding
tissue. This layer is composed of connective tissue with varying amounts of elastic and
collagenous fibres
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Figure 3.2 Layers of the artery
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3.2.2 The lower limb arterial anatomy
The largest artery in the body is the aorta. It is connected to the heart's left ventricle and
it carries oxygenated blood around the body. It has many branches which feed all the
various abdominal organs. At L4 or the level of the umbilicus, the aorta divides into
two main branches – these are called the common iliac arteries (CIA). At the brim of
the pelvis the CIA further branches into the internal (IIA) and external iliac arteries
(EIA). The IIA supplies the pelvis muscles. The EIA descends to groin level and
becomes the common femoral artery (CFA). See figure 3.3 below.

Figure 3.3 The iliac arteries
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The CFA just below groin level divides to become the profunda femoris (PFA) and the
superficial femoral artery (SFA). The PFA supplies the thigh muscles. The SFA
continues to knee level and becomes the popliteal artery (PA). Just below knee crease
level, the anterior tibial artery (ATA) arises off the PA and this vessel runs on the lateral
aspect of the calf to ankle level where it continues into the foot as the dorsalis pedis
artery (DPA). The PA continues after the ATA take off as the tibioperoneal trunk
(TPT). The TPT divides into the posterior tibial artery (PTA) and the peroneal artery
(PER). See figure 3.4 below.

Figure 3.4 The lower limb arteries
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The PTA supplies blood to the posterior calf muscles and plantar surface of the foot. It
gives rise to the medial and lateral plantar arteries. The PER supplies blood to the calf
and ankle muscles. It divides on the lateral aspect of the foot and forms the external
malleolus artery, lateral tarsal artery and external plantar artery. The plantar arteries,
lateral, medial and deep form a looping web across the foot and down through each toe.

Figure 3.5 The foot arteries
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3.3

The Microcirculation

Blood circulates from the heart to the arteries, to arterioles (small arteries), to
capillaries, to venules (small veins), to veins and back to the heart. The microcirculation
is the circulation of the blood in the smallest blood vessels, the main function of which
is to deliver oxygen (O2) and nutrients and to remove carbon dioxide (CO2). Essentially
it is responsible for the regulation of tissue perfusion. It also serves to regulate blood
flow and tissue perfusion which can affect blood pressure and the body’s responses to
inflammation such as oedema.
It is composed of terminal arterioles, capillaries, and venules that drain capillary blood.
Arterioles: These are the vessels on the arterial side of the microcirculation. They are
surrounded by smooth muscle cells and measure approx.10-100µm in diameter. They
contract and relax their diameter in response to a diverse range of stimuli, which means
blood flow in the microcirculation remains constant despite changes in systemic blood
pressure. They are responsible for carrying the blood to the capillaries.
Capillaries: These have no smooth muscle cells and measure between 5-8µm in
diameter. Approximately 7% of the body’s blood is in the capillaries and this is where
the exchange of substances occurs. Precapillary sphincters control the flow of blood
between the arterioles and the capillaries. The displacement of materials between the
interstitial fluid and the blood is called the capillary exchange. The precapillary
sphincters contain muscle fibres allowing them to contract. If the sphincters are open
blood can flow freely to the capillary bed which is where fluids, gasses, nutrients and
wastes are exchanged between the blood and the body cells. If the sphincters are closed
blood cannot flow through the capillary bed and must flow directly from the arteriole
to the venule.
Venules: Blood then flows out of the capillaries and into the venules, which have a
little smooth muscle and are approx. 10-200µm in diameter. The blood flows from the
venules into the veins. In addition to these blood vessels, the microcirculation also
includes lymphatic capillaries and collecting ducts.
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Figure 3.6 The microcirculation in the foot

Blood is supplied to all parts of the body at all times but all capillary beds do not contain
blood at all times. Blood is diverted to the various parts of the body that require it most,
at a particular time.

One of the most important issues when it comes to ulcers is firstly determining the cause
and then ensuring that the area is receiving enough nutrients to encourage and promote
healing.

Transcutaneous oximetry (tcpO2) is considered the gold standard for assessment of
tissue oxygenation, an essential test in assessing the probability of wound healing (Lee
Y.N. et al. 2014). tcpO2 is a local non-invasive measurement reflecting the amount of
O2 that has diffused from the capillaries through the epidermis to a Clark-type electrode
at the measuring site. It provides instant continuous information about the body’s ability
to deliver oxygen to the tissue and thereby measures nutritive blood perfusion at a given
site. With the current emphasis on cost savings in the health service, this non-invasive
test is gaining importance as a tool for predicting healing. Physicians use this data to
aid decision making with regards to treatment plans for their patients. In being able to
determine the tissue oxygenation status of a wound area, the physician can out rule any
treatment options which would be ineffective and move directly for the quickest most
efficacious treatment. The microcirculation is important to consider in the diabetic
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patient group especially in the cases where traditional tests such as TBI’s aren’t possible
due to ulceration or previous amputation.
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Chapter 4

Physics and Instrumentation
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4.0

Physics

The following chapter looks at the physics behind ultrasound and the basic principles
used in measuring the flow or velocity of flow in the lower extremities.

4.0.1 Soundwaves
Soundwaves are described as mechanical vibrations of particles or molecules within a
medium. The vibration of one particle transmits a corresponding vibration to an
adjacent particle and so a wave is passed through a medium. The transmission of a
soundwave through a medium occurs at a fixed speed which is determined by the
elasticity and density of a particular medium. Frequency or pitch is described as the rate
at which an individual particle vibrates. This is measures in Hertz (Hz) and is the
number of cycles per second.
Ultrasound is defined as sound which has a frequency above the audible range of
humans which is greater than 20 kHz.
Soundwaves have a longitudinal, sinusoidal waveform which varies from high
pressures (compression) to low pressure (rarefaction). Wavelength is the distance
between identical points in a cycle.

Figure 4.1 A Soundwave
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4.0.2 The Doppler Effect
The Doppler Effect was first described by an Austrian physicist, Christian Andreas
Doppler in 1842. It is described as a shift in the observed frequency of a radiated wave
motion when there is movement between the source of the radiation and the observer.
The classic example is an ambulance siren. This sounds higher pitched when it is
travelling towards you and lower pitched when travelling away.

Figure 4.2 The Doppler Effect

If the source and the observer are both stationary, then emitted waves travel through
the intervening medium at a constant and regular rate, and pass the observer at the same
rate as transmitted. If the source is moving towards a stationary observer, the
wavelength becomes shorter as the source gets closer, and even though they pass the
observer at the same speed, the observer experiences a higher frequency. Conversely if
the source is moving away from the observer, the wavelength is increased and the
observer experiences a lower frequency.
If the observer is moving towards a stationary source, the observer intercepts the waves
at a faster rate, and experiences a higher frequency. Conversely if the observer is
moving away from a stationary source, they intercept the waves a slower rate, and
experience a lower frequency.
In the case of both a moving source and a moving observer, the difference between both
the transmitted and received frequencies of the waveforms is called the Doppler Shift.
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This can be positive or negative depending on whether the blood flow is going towards
the transducer or away from it.
In vascular ultrasound the Doppler shift frequency provides the basis for calculating the
velocity of flow in the vessel under investigation. It falls within the audible hearing
range of the human ear and so the pitch can be heard by the physiologist. The method
of applying the Doppler principle in ultrasound differs from the original theory in that
the moving targets are blood cells, so that the transducer is both the source and the
receiver. The reflected or scattered waveform and the corresponding change in
frequency can be observed with the difference between the transmitted and received
frequencies being referred to as the Doppler shift frequency (fd).

Equation 4.1
The Doppler shift frequency

Fd

=

2ft V Cos θ
C

ft= the frequency emitted by the transducer
θ = the angle between the Doppler bean and the direction of flow
C = velocity of sound in the medium – approx. the same in all soft tissue (1540 m s-1)
V = the blood cell velocity
The angle of insonation (θ) is very important in the clinical use of Doppler. If θ = 0°,
Cos θ = 1 and the maximum Doppler shift frequency is obtained for a given velocity.
As θ increases the value of Cos θ decreases and hence the Doppler shift frequency
decreases until at θ = 90° (Cos θ = 0) and there is no Doppler shift at all and no audible
signal. To obtain reliable quantitative Doppler data in clinical practice, θ should not
exceed 60°. (The Society for Vascular Technology of Great Britain & Ireland 2001).
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Figure 4.3 The Angle θ
The use of Doppler in clinical investigations was not accomplished until the 1960’s
with the development of the first Doppler probe by Satomura in 1959 (Coman I.M.
Popescu B.A. 2015).
Currently Doppler ultrasound is routinely used as a non-invasive test to examine and
evaluate the movement of blood flow through arteries and veins. It enables medical
staff to diagnose multiple conditions such as arterial narrowing, deep vein thrombosis,
heart and numerous organ defects.
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4.1

Instrumentation

This section will discuss the actual equipment used in practice to assess perfusion, both
with regards to actual blood flow and also oxygenation of tissue.

4.1.1 Doppler Instruments
In clinical practice there are two types of Doppler instrumentation – continuous wave
(CW) and pulsed wave (PW). These can also be described as either imaging or nonimaging. Non-imaging techniques (CW) include the traditional hand held continuous
wave Doppler units used in the detection of peripheral pulses. These are used when
preforming Ankle Brachial Indices (ABI’s) or when recording the Brachial systolic
pressure for a set of TBI’s. Imaging techniques include colour Doppler, power Doppler
and spectral pulsed wave Doppler and are always used in conduction with B-Mode
imaging used in general ultrasound.
Continuous Wave Doppler are the simplest Doppler devices available and are
typically a hand held unit with a pencil probe attached.

Figure 4.4 Image of CW pencil probe

The pencil probe transducer consists of two piezoelectric elements or crystals mounted
on the end. One crystal acts as the emitter and the other one as the receiver. The two
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crystals are set at angles to each other so that the emitted and received beams overlap
or converge to form a long narrow crossover region. This is where the Doppler signal
can be detected. The detected signal is obtained from all the moving targets passing
through this region. Continuous wave devices are widely used today and have many
clinical applications such as foetal heart monitoring and the detection of peripheral
pulses. However, their main disadvantage is that any sound detected in the crossover
region can be heard by the operator. For example flow from more than one vessel may
be heard at the same time such as an artery and a vein, resulting in a mixed arterial and
venous signal being detected. The biggest advantage is that they are inexpensive and
easy to use by a skilled operator.
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4.1.2 Photo Plethysmography (PPG)
Photoelectric plethysmography is used to obtain the systolic pressures at the toe when
performing a TBI exam. The sensor of the PPG contains an infrared light which has
an emitting diode and a phototransistor. When this sensor is placed on the limb, the
infrared light is transmitted into the superficial layers of the skin and the reflected
portion is received by the phototransistor.

Figure 4.5 Image of PPG
The resulting signal is proportional to the quantity of red blood cells in the cutaneous
circulation i.e. it measures changes in light absorption (Zwiebel W.J. and Pellerito J.
2000).
A conventional pulse oximeter monitors the perfusion of blood to the dermis and
subcutaneous tissue of the skin. PPG is a low cost and simple technique used to detect
blood volume changes. It is non-invasive and in recent years there has been a resurgence
of interest in the technique and its applications in a clinical setting.
The PPG waveform comprises a pulsatile waveform superimposed on a slowly varying
baseline with various lower frequency components. The pulsatile one is attributed to
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cardiac changes in the blood volume with each heartbeat, and the second one is
attributed to respiration, sympathetic nervous system activity and thermoregulation.
The below diagram figure 4.6 shows a typical PPG signal without motion artefact.

Figure 4.6 PPG Waveform
PPG technology is being used in a wide range of commercially available medical
devices for measuring oxygen saturation, blood pressure and arterial stiffness, cardiac
output, assessing autonomic function and detecting peripheral vascular diseases (Allen
J. 2007). For our purposes we use it for measuring blood perfusion in the toes.
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4.1.3 The Clark Electrode
Lealand C Clark is responsible for the development of this electrode and it is used to
quantify or measure oxygenation tension at a particular point on the skin. In the field
of vascular diagnostics it is used in the tcpO2 test. A transcutaneous oximeter uses a
clarkpolarographic electrode which is modified to contain both a heating element and
a thermistor.
The heating element maintains a pre-set temperature of 42 – 45°C.
The role of the thermistor is to continuously monitor this.
A phosphate buffer and a potassium chloride solution is contained between the
electrode surface and an oxygen permeable membrane.

Figure 4.7 Clark-type electrode
(A) Pt- (B) Ag/AgCl-electrode (C) KCl electrolyte (D) Teflon membrane (E) rubber
ring (F) voltage supply (G) galvanometer
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The electrode is attached to the skin by an adhesive fixation ring which is then filled
with the contact solution. This maintains a continuous liquid pathway for the oxygen to
diffuse from the skin to the electrode. A constant polarizing voltage is applied to the
cathode within the sensor. The polarized oxygen electrode provides electrons to reduce
molecular oxygen as it arrives at the electrode surface. Separate to the polarizing
voltage an extra current is derived from the reduction of oxygen at the electrode surface
as the oxygen is converted to hydroxyl ion. The current generated is directly
proportional to the number of oxygen molecules in the solution. Hence the oxygen
sensor can be used to determine the oxygen tension in the skin capillaries.

Figure 4.8 Image of tcpO2 probe

This chapter outlined the basic physics principles and the practical application of both
the ultrasound and oximetry modalities. The next section, chapter 5, method of data
acquisition, will outline patient selection parameters and the process of the utilisation
of these modalities in providing quantitative and qualitative data.
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Chapter 5

Method of data acquisition
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5.1

Methology

In 2008 Tallaght hospital introduced a new multidisciplinary diabetic foot protection
clinic (DFPC). This clinic focused on treating and managing diabetic patients with
existing ulceration. Every patient attending the clinic had access to Endocrinology,
Orthopaedic Surgery, Podiatry, Orthotics, Tissue Viability and Vascular Surgery in a
“one stop shop” environment. Results from between 2006 and 2010 showed a total of
221 lower limb procedures were performed. The number of amputations decreased
from 12 during the control period (2006 – 2008) to 7 in the study period (2008 – 2010).
On costing the clinic activity there was an overall saving of €114,063 per years
associated with the introduction of the DFPC (Nason G.J. et al. 2012).
In 2012 the vascular laboratory sought to further enhance the diagnostic services it
offers, in a bid to improve the support it provides to this clinic and indeed ulcer patients.
The complexity of the patients presenting with ulceration was noted to include toe
amputations and/or ulcers often preventing the standard TBI test from being performed.
This led to an alternative test being sought to help with this patient cohort. There are
several factors that can influence the wound healing process and one such factor is
tissue oxygenation surrounding the wound, thus an adequate oxygen supply is essential.
This study was undertaken to audit results from a test introduced into the vascular
service in December 2012 called transcutaneous oximetry (tcpO2). tcpO2 is a
measurement of tissue oxygenation at a particular site. It has been growing in
recognition as a test to help aid a doctor’s decision in predicting healing or whether an
amputation will be the end result. In practice, patients often require an admission to
hospital to observe wound healing and investigate the initial cause of the wound. Those
failing to progress during admission, or those who fail to heal post intervention and/or
discharge, often require readmission for further procedures. Given the introduction of
this test did not cost the hospital with regards additional staffing or space, and only
required minimal training, the question is, has the introduction of this test provided any
clinical diagnostic value?
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5.1.1 Patient selection
For the purposes of this study, patients were selected from a population which presented
to both the vascular surgical outpatients (OPD) and the diabetic foot protection clinic
(DFPC) with ulceration to a lower limb. Inpatients were also included who were
admitted under the care of the vascular team for treatment of an active ulceration.
Patients were only included in the audit if they had both tests performed ie. a set of
TBI’s and a tcpO2 exam. Both diabetic and non-diabetic patients were included and in
some cases both the limb with ulceration and the contra-lateral limb had tcpO2
performed.
The medical history of all patients was reviewed and noted to include the following
details
i)

Smoker / ex-smoker / non-smoker

ii)

Medicating to treat hypertension

iii)

On statin therapy

iv)

Diabetic and if so whether Type 1 or Type 2

It is widely accepted that these characteristics are known to be commonly associated
with vascular disease and as previously outlined in chapter 2 section 2.1 vascular
disease can be prevalent in the diabetic ulcer patient.
All results have been collated for the three year period and analysed.
Of note it is important to recognise that there may have been limitations within the
study with regard to patient compliance with medications. Patients may have been
hypertensive or hypercholesteraemic despite attempts at best medical management. It
was not possible to quantify patient compliance with medical advice and medication
requirements. It also cannot be ruled out if there were undiagnosed diabetics within the
study. As discussed in section 2.0.3 there are significant numbers of undiagnosed
diabetics in both Ireland and worldwide. There may also be limitations with regard to
smoking status within the study. It is difficult to qualify the smoking status of patients
and indeed this is a major challenge across many areas of healthcare.
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5.2 Demographics
Demographics are divided into two groups
1) 5.2.1 analyses participant demographics
2) 5.2.2 analyses test variables.

5.2.1 Participant demographics
In the audited time frame, December 2012 – December 2015, there were a total of 247
patients with ulceration which attended the vascular laboratory who had a tcpO2 exam
performed. This number of patients represented 48% of all ulcer patients that attended
the laboratory in this time period. The other 52% of patients had a TBI exam only.
There was no formal criteria or protocol established for ordering tcpO2 as this was a
trial period to investigate the usefulness of the test itself. The placement of requests for
tcpO2 exams were consultant led and determined by a clinical decision made by the
vascular consultant bearing in mind the limited resources, primarily time, available.
These patients represented approx. 14% of all patients going through the laboratory for
the investigation of peripheral vascular disease. The inclusion criteria for this study was
any person with an ulceration presenting to the vascular laboratory between December
2012 – December 2015 who had both a tcpO2 test performed and a corresponding TBI
test. The age range was 32 – 94 years old with a mean age of 67.5years and a median
age of 69 years. Of these patients 163 (66%) were male and 84 were female (34%),

5.2.2 Test variables
Of the 247 patients, 105 of them had tests performed bilaterally accounting for 210
tests. There were 142 single leg tests which resulted in an overall total of 352 tests
performed. Of these, 42 tests were excluded from the initial analysis – 30 tests had no
corresponding TBI’s or absolute toe pressure (ATP) as a result of a toe or transmetarsal
amputation (TMA), incompressible vessels, or due to excessive patient movement. A
further 12 tests were excluded as these patients went directly to theatre and were only
seen post intervention. This resulted in a total number of 310 tcpO2 tests in the three
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year period which had a corresponding set of TBI’s performed. These were
retrospectively analysed.
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All statistical analysis was carried out on the total numbers of tests. See table figure 5.2.
Tests for analysis
Male
Female
Current Smoker
Current Non Smoker
Hypertension
No hypertension
Statin Therapy
No Statin Therapy
Ulceration
No Ulceration
Diabetic
Type 1
Type 2
Non Diabetic

n
310
204
106
77
233
238
72
215
95
228
82
204
36
168
106

Table 5.1 Test variables
Seventy seven (25%) tests were carried out on current smokers and two hundred and
thirty three (75%) were current non-smokers with one hundred and twenty five of these
being ex-smokers. There were 238 (77%) tests carried out on patients who were
medicating for the treatment of hypertension and 215 (69%) on statin therapy. A total
of 228 tests (74%) were performed on ulcerated limbs. Two hundred and four (66%)
tests were carried out on patients who were diagnosed as diabetic with 36 (18%) who
were classed as Type 1 and 168 (82%) as Type 2. There were 106 (34%) tests carried
out on non-diabetics.
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5.3

Assessment of Lower limb arterial disease

All patients had 2 test performed, tcpO2 and a set of toe Brachial indices (TBI’s).

5.3.1 Transcutaneous Oxygen Pressure (tcpO2)
tcpO2 is a well-established non-invasive method which quantifies the amount of oxygen
that diffuses from the capillaries and through the skin and only reflects the status of the
capillaries i.e. nutritive flow.
Patient Preparation
No specific preparation was required on behalf of the patient for this test. Shoes, socks
and any bulky clothing on their upper body were removed. The test was explained in
full to the patient and any questions were answered. Patients lay supine on an
examination couch.
Equipment
All tcpO2 tests were carried out on a Radiometer TCM400 machine.

Figure 5.1 tcpO2 machine
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Electrode prepared / calibrated
All electrodes being used were placed in the channel on the machine and calibrated.

Method for performing tcpO2
1. Patients were examined while lying supine.
2. The sensor site was located. A single standardised location for positioning of the
sensor was chosen on all patients (where possible). This was on the dorsum of the foot.
It was important that this site did not directly overlie a bony prominence or any
superficial vessels. Flat or convex areas were most reliable. If it was not possible to use
this site due to an area of ulceration the site nearest it was used.

Figure 5.2 Picture of tcpO2 probe in situ

3. The site was then prepared as follows. The chosen area was stripped with adhesive
tape to remove any loose skin cells. Any hair was removed if deemed necessary. The
area was cleaned with an alcohol wipe. Any open skin areas were avoided.
4. The fixation ring was then attached using its adhesive backing.
5. The centre of the fixation ring was pressed onto the measuring site with a finger and
a finger was ran around the rim circumference.
6. It was important that the placement was completely airtight.
7. Approx. 4 - 5 drops of contact liquid was then placed in the fixation ring and the
electrode was then attached by aligning the arrow on the sensor with the mark on the
fixation ring.
46

8. The sensor was turned 90o clockwise to fasten it in place securely. It was important
that this connection was also airtight. To increase the permeability of the skin to oxygen
molecules at the measuring site, the sensor maintained a pre-set temperature of 43 –
45oC.
9. The test was performed for 20 minutes. As per supplier protocol 20 minutes was
adequate physiological stabilisation time for an accurate reading. This time allowed the
sensor to heat the skin and encourage the arteries dilate. Results were recorded at the
end of this period.
10. In the case where the reading at the end of the 20 minutes period was less than
40mmHg the patient was given 5L of 100% oxygen per minute through a rebreather
mask and the test continued for a further 10 minutes.
Results were also recorded at the end of this period.

Interpretation of tcpO2 measurements
A baseline measurement of < 40mmHg was selected as the cut-off below which the test
was considered as abnormal and indicative that a wound could be unlikely to heal.
A baseline measurement of > 40mmHg was selected as the cut-off above which there
should be spontaneous wound healing.
It has been previously determined that values near the wound that are below 40mmHg
are considered to have moderate – severe hypoxia and are potential candidates for
aggressive wound healing and / or revascularisation (Sheffield P.J. 2004).
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5.3.2 Toe Brachial Indices (TBI’s)
Patient Preparation
No specific preparation was required on behalf of the patient for this test. Shoes, socks
and any bulky clothing on their upper body were removed. The test was explained in
full to the patient and any questions were answered.

Equipment
All TBI’s were carried out on an Elcat Vasolab 320 machine.
Two standard blood pressure arm cuffs were used as were two 2.5cm toe pressure cuffs.
An 8MHz continuous wave Doppler probe was used to insonate the Doppler waveform
in the Brachial artery (BA) in each arm.

Figure 5.3 Picture of TBI and PPG machine
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Method for performing a TBI
1. Patients were examined while lying supine.
2. A pneumatic cuff was carefully placed around each of the patient’s arms.

Figure 5.4 Picture of arm cuff in situ

The end of an 8MHz continuous wave Doppler probe was covered in ultrasound gel
and the BA in each arm was insonated.

49

3. While the probe was held static and the physiologist listened to the BA Doppler
signal, the pneumatic cuff was inflated until the signal was inaudible. This indicated
the occlusion of the artery.
4. The cuff was then slowly deflated until the BA Doppler signal returned sharply. The
systolic pressure reading at this point was recorded and the remainder of the air in the
cuff was rapidly deflated.
5. Steps 2 to 4 were repeated for the left arm.
6. A toe cuff was attached to each of the patient’s hallux and the photoplethysmogram
(PPG) sensor was also attached. The pressure in both hallux was recorded
simultaneously.

Figure 5.5 Picture of toe cuff and PPG in situ
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7. When a steady arterial waveform was displayed on the screen, the cuff was inflated
until the waveform was obliterated indicating occlusion of the digital artery
8. The cuff was then slowly deflated until the waveform reappeared. The systolic
pressure reading at this point of return was recorded.

Interpretation of Toe Brachial Measurements
In the normal limb the baseline digital index should be greater than or equal to 0.6
(Cole, Norris and Walker. 2000). TBI’s are calculated as described in equation 5.1
below. If PAD is present this value will drop accordingly to its severity.

Equation 5.1

TBI =

Toe systolic pressure
Highest Brachial systolic pressure

A systolic toe pressure measurement of < 30mmHg indicates the presence of critical
ischemia (Society for Vascular Technology of Great Britain and Ireland 2001).
The digital arteries in the great toe are less affected by arterial calcification. However,
this test is limited if the great toe has a wound/ulcer or there has been a previous
amputation. Interpretation of toe pressure and TBI vary in the literature. In general, an
absolute toe pressure (ATP) > 70 mmHg or a TBI > 0.6 is normal, with anything below
these are diagnostic of PAD (Society for Vascular Technology of Great Britain and
Ireland 2001).
In the diabetic group, the microcirculation often also needs to be assessed and may
provide alternative diagnostic information not possible to obtain due to amputation or
ulceration from the usual tests such as TBI’s. Increasingly the laboratory has more
patients attending who have had previous amputations and so this alternative test is
required.
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Chapter 6

Comparison of risk factors between
tcpO2 versus the absolute toe pressure
results.
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Comparison of risk factors between tcpO2 versus absolute toe pressure
(ATP) results

6.1

Aim

The aim of this chapter is to statistically analyse the results from the two tests
performed, TBI’s and tcpO2, and to assess the various risk factors of smoking,
hypertension, statin therapy and diabetes i.e. does a relationship exist between these
factors relative to the results?

6.2

Method

Statistical analysis of initial test results looked at all tests in the 3 year period. The
objective of this statistical analysis was to determine if the average outcomes of the two
sets of data are significantly different from each other.

Initially, the distribution of results was visually assessed for each group being tested.
This visual assessment was conducted to understand how best to statistically assess for
differences. The distributions of test groups were seen to converge to a normal
distribution though slightly skewed in some cases.
It is also important to state that results are applicable to ulcer patients and not to the
wider population in general.

Given that the objective remains to compare an outcome and that the assumption of
normality is less important as sample size increases (Lumley T. 2002), it was decided
to use student’s t tests in all cases to test for differences in the means. The tests were
evaluated at a 99% significance level (p-value < 0.01) to provide a stronger degree of
certainty in the results compared to a more widely used 95% significance level.
All analysis was performed using Microsoft excel 2013.
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6.3

Results

All risk factors were assessed and compared with regards to both tests.

Smoking
Test
Smoker
Non Smoker
P-Value
Outcome

tcpO2 (mmHg)
34
41
p = 0.006
Indicated difference

ATP (mmHg)
56
72
p = 0.01
Indicated difference

Table 6.1 Analysis of smokers V’s non-smokers.

Mean (± SD) tcpO2 between the smokers and the non-smokers were as follows:
Smokers 34 ± 20 mmHg and the non-smokers 41 ± 19 mmHg.
There was an indicated difference (p = 0.006) between the mean tcpO2 in smokers and
the mean tcpO2 in the non-smokers.

Mean (± SD) absolute toe pressures between the smokers and the non-smokers were as
follows:
Smokers 56 ± 55 mmHg and the non-smokers 72 ± 46 mmHg.
There was an indicated difference (p = 0.01) between the mean absolute toe pressures
in smokers and the mean absolute toe pressures in the non-smokers.
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Hypertension
Test
Hypertension
Non Hypertension
P-Value
Outcome

tcpO2 (mmHg)
38
43
p = 0.08
No indicated difference

ATP (mmHg)
64
83
p = 0.003
Indicated difference

Table 6.2 Analysis of those medicating for hypertension V’s those not medicating
for hypertension

Mean (± SD) tcpO2 between patients medicating for hypertension and those not
medicating for hypertension were as follows:
Those on anti-hypertensive medications 38 ± 20 mmHg and those not on antihypertensive medications 43 ± 18 mmHg.
There was no indicated difference (p = 0.08) between the mean tcpO2 in those on antihypertensive medications and those who were not.

Mean (± SD) absolute toe pressures between patients medicating for hypertension and
those not medicating for hypertension were as follows:
Those on anti-hypertensive medications 64 ± 48 mmHg and those not on antihypertensive medications 83 ± 50 mmHg.
There was an indicated difference (p = 0.003) between the mean absolute toe pressures
in those on anti-hypertensive medications and those who were not.
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Statin therapy
Test
Statin therapy
Not on statin therapy
P-Value
Outcome

tcpO2 (mmHg)
39
40
p = 0.56
No indicated difference

ATP (mmHg)
64
77
p = 0.03
No indicated difference

Table 6.3 Analysis of those on statin therapy V’s those not on statin therapy

Mean (± SD) tcpO2 between patients on statin therapy and those not on statin therapy
were as follows:
Those on statin therapy 39 ± 20 mmHg and those not on statin therapy 40 ± 20 mmHg.
There was no indicated difference (p = 0.56) between the mean tcpO2 in those on statin
therapy and those not.
Mean (± SD) absolute toe pressures between patients on statin therapy and those not on
statin therapy were as follows:
Those on statin therapy 64 ± 47 mmHg and those not on statin therapy 77 ± 53 mmHg.
There was no indicated difference (p = 0.03) between the mean absolute toe pressures
in those on statin therapy and those not. Of note, if the standard p value of <0.05 was
used, this may of suggested a difference between the groups
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Diabetes
Test
Diabetic
Non Diabetic
P-Value
Outcome

tcpO2 (mmHg)
39
40
p = 0.73
No indicated difference

ATP (mmHg)
68
68
p = 0.96
No indicated difference

Table 6.4 Analysis of diabetics V’s non-diabetics
Mean (± SD) tcpO2 between patients who are diabetic and those who are not were as
follows:
Patients who are diabetic 39 ± 20 mmHg and those who are not 40 ± 19 mmHg.
There was no indicated difference (p = 0.73) between the mean tcpO2 in the diabetic
and the non-diabetic patients.

Mean (± SD) absolute toe pressures between patients who are diabetic and those who
are not were as follows:
Patients who are diabetic 68 ± 49 mmHg and those who are not 68 ± 50 mmHg.
There was no indicated difference (p = 0.96) between the mean ATP’s in the diabetic
and the non-diabetic patients.
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6.4

Discussion

This diagram, table 6.5, is a summary of the statistical analysis outcomes detailed in
the previous section.
Tests

tcpO2
Indicated
difference

Smokers V non-smokers

ATP
No indicated
difference

√

Indicated
difference

No indicated
difference

√

HTN V's no HTN

√

√

Statins V's no Statins

√

√

Diabetes V's no diabetes

√

√

Table 6.5 Summary of statistical analysis per risk factor
The analysis in section 6.3, has shown that there is an indicated difference in the mean
ATP’s and tcpO2 results between the smoking and the non-smoking groups. When
comparing the smokers against the non-smokers with regards outcomes of these two
tests, the results in the smokers in both tests are significantly lower than in the nonsmokers. This outcome supports evidence that smoking impairs the body’s ability to
deliver oxygen effectively (Lee C.L. Chang W.D 2013, Nadel J.A. Comroe J.H. 1961)
and is a significant factor in PAD due to atherosclerosis of the lower limb arteries. This
ultimately can lead to ulceration.
The smoking prevalence in Ireland in 2015 was 19.2%, with the levels of smoking
highest in younger adults aged between 18 – 24 years at 27.2% and in the 25 – 34 year
olds at 28.5%. The lowest prevalence was in the over 65 year olds at 8.6% (Health
Service Executive 2015). There are estimated to be 5500 smokers dying each year from
tobacco related diseases (Health Service Executive 2016). This represents
approximately 19% of all deaths. Of these deaths, 30% are attributed to circulatory
diseases (U.S. Department of Health Human Services 2014).
Cigarettes are known to contain over 4000 toxic chemicals (Ginzel K.H. 2016).
Nicotine is one of the main ingredients in a cigarette and this is a highly addictive
substance. It is also a vasoconstrictor which is known to increase the adhesiveness of
platelets in the blood, hence raising the risk of a microvascular occlusion. This in turn
can lead to a reduction in nutritional blood flow to the skin. Another substance in
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cigarettes is carbon monoxide. This poisonous gas binds itself to the haemoglobin in
the bloodstream and prevents it from carrying enough oxygen around the body.
The association between cigarette smoking and delayed wound healing is well
recognised (Silverstein P. 1992) and frequently leads to impaired perfusion. Smoking
is also known to raise blood pressure which is a risk factor for other diseases such as
stroke and heart attack.
Statistical analysis in Section 6.3 shows that there was an indicated difference noted
between the ATP’s in those on antihypertensive medications and those not. The ATP’s
were lower in those tests taking hypertensives. There was no difference noted in the
tcpO2 tests in either those medicating or those not, suggesting, that in this study
hypertensive medications did not appear to affect oxygenation of the tissue.
Antihypertensives are a drug used to treat hypertension – high blood pressure. There
are many classes of this drug type, which are used to lower the blood pressure by
different means. The most commonly used drugs are calcium channel blockers,
angiotensin-converting-enzyme (ACE) inhibitors, diuretics and beta blockers. The type
of medication initially chosen to treat hypertension has been the subject of several large
studies and resulting national guidelines such as the AASK trial (African American
study of kidney disease and hypertension), ALLHAT trail (antihypertensive and lipid
lowering treatment to prevent heart attack trial), NICE (National institute for healthcare
and care excellence), and JNC8 (Eight joint national committee on the prevention,
detection, evaluation and treatment of high blood pressure) to name a few (Dewland
T.A. et al. 2016, James P. A. et al. 2014, National Clinical Guideline Centre 2011,
Norris et al. 2006). These trials looked at the various methods used to treat
hypertension. They also assessed mono therapy versus dual therapy with regard to the
various combinations of treatment in the various patient groups depending on risk
factors. Treatment of hypertension needs to be individualised. Antihypertensives
reduce cardiac output and/or peripheral resistance. Hypertension is associated with all
forms of cardiovascular disease and peripheral arterial disease (PAD). The relative risk
for developing PAD is noted to be less for hypertension than other risk factors such as
diabetes or smoking (Norgren L. et al. 2007). The interaction between tissue
oxygenation and antihypertensives is poorly studied.
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The statistical analysis in Section 6.3 shows that there was no indicated difference
noted between either the tcpO2 or ATP’s in those that were on statin therapy versus
those not.
This suggests, that in this study statins did not appear to affect oxygenation of the tissue
or blood perfusion. Of note, if the standard p value of <0.05 was used, this may of
suggested a difference between the groups.
Statins are described as a lipid lowering drug and can be grouped into either low
intensity, medium intensity or high intensity categories (NICE guidelines).
The type of medication initially chosen to treat patients has also been the subject of
many studies, with the NICE guidelines advocating all diabetics should be placed on
statin therapy (National Institute for Health Care Excellence 2016a). There appears to
be no one direct cause for hyperlipidaemia, so the treatment also must be multifaceted.

There is evidence that treatment of hyperlipidaemia reduces both the progression of
PAD and the incidence of claudication (Norgren L. et al. 2007). This directly impacts
on disease progression which can lead to ulceration. Statins not only lower the risk of
vascular events but they also improve the symptoms of PAD. (Coppola G. Novo S.
2007). The Heart Protection Study (HPS) has published evidence that supports the
routine use of statins in patients with PAD regardless of their cholesterol levels (Al
Mahameed A. 2009, Heart Protection Study Collaborative Group 2002). It has also been
suggested that cigarette smoking may enhance the effect of hypercholesterolemia. As
is the case with antihypertensives the interaction between tissue oxygenation and statins
is poorly studied.

The statistical analysis in Section 6.3 shows that there was no indicted difference
noted between either the tcpO2 or ATP’s in those that were diagnosed diabetic versus
those not.

In general all diabetic patients tend to be medicated tightly in a bid to reduce their
long term complications, including arterial disease, renal failure, ocular complications
and peripheral neuropathy. Many studies have shown an association between diabetes
mellitus and the development of PAD. Claudication is approximately two times more
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common in diabetic patients than in non-diabetic patients. In patients with diabetes,
for every 1% increase in haemoglobin A1c there is a corresponding 26% increased
risk of PAD (Norgren L. et al. 2007). PAD in patients with diabetes is more
aggressive compared to the non-diabetics, and coupled with neuropathy this can lead
to significant problems as mentioned earlier in chapter 2, section 2.1.

Sixty six percent of tests in the study where diabetic with 74% of tests having an ulcer.
The sample patients in this study is based primarily on those with ulcers and/or those
referred to a vascular or a foot protection clinic.

Can the majority of ulcers in these patients be considered neuropathic in origin (rather
than vascular) and can this account for the absence of a difference between diabetics
and non-diabetics in this study population? Is neuropathy the more dominant cause of
ulceration in these diabetic patients rather than arterial disease? In addition to this, while
the proportion of those with PAD is higher among diabetics than in the normal
population, the non-diabetic group in this study presented due to the fact that there was
a concern about their peripheral arterial supply (they presented with an ulcer). This will
be further discussed in chapter 8.

The outcome of this chapter would confirm smoking as the one single risk factor that
has had a negative impact on both tests and hence effects both the macro and micro
circulation. In patients who are smokers, the body’s ability to heal ulceration is
diminished with regards to both blood perfusion and tissue oxygenation. Hypertension
and hypercholesterolemia are closely linked to the severity of arterial disease and often
medications used to treat them are commonly prescribed with a dual function eg:
antihypertensives can also be used as a vasodilator to improve flow to extremities and
not just or only for hypertension. The outcomes in this work are suggestive, that these
medications have an effect on the macro circulation only, and seem to have spared the
micro circulation.

The tests in this audit have a large number of diabetics (66%) and a large cohort of
ulcerations (74%), which have a burden of disease that we know will result in the
prescribing of the aforementioned medications. International research has shown that
these risk factors have a proven negative impact on ATP’s and TBI’s and the
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prescribing of these drugs is performed in a bid to reduce this and its severity. This
study has determined that diabetes or the use of antihypertensives and/or on statin
therapy does not have a clearly defined impact on tcpO2 results, whereas they do have
an impact on ATP’s. In a certain patient cohort both tests should be considered. tcpO2
is a non invasive and cheap test, which can provide additional diagnostic information,
that can perhaps be equally as valuable as a set of TBI’s in assessing perfusion and
healing potential. It is also seen in this study that they are not affected by certain risk
factors to the same extent as ATP’s and TBIs are.
In the following chapter, further analysis was performed by directly comparing the
results from the two tests against each other. This will aid in better determining the role
of tcpO2.
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Chapter 7

Comparison of results between tcpO2
and the TBI tests
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Comparison of results between tcpO2 and the TBI tests
7.1

Aim

The aim of this chapter is to analyse initial results of TBI’s and tcpO2 examinations in
all patients, and the relationship that exists directly between the two tests, if any.

7.2

Method

This study has looked at two different tests performed on a set of patients which have
all presented to the vascular laboratory with foot ulceration. TBI’s looked at pressure
as an indicator of arterial perfusion of a limb/toe and tcpO2 looked at tissue oxygenation
at a particular site on the foot. In some cases, the non-ulcerated contralateral limb had
both tests also recorded. Firstly a correlation coefficient was performed on the results
from both tests in Microsoft excel 2013. Subsequently, the results from all the tests
where plotted against each other using an X,Y scatter graph. This was also performed in
Microsoft excel 2013.

7.3

Results:

Correlation coefficient: When the TBI’s and tcpO2 results were compared, the
correlation coefficient was 0.49. When absolute toe pressures and tcpO2 results were
compared the correlation coefficient was also 0.49.

64

Scatter Graph:

TBI's V tcpO2

B (Low TBI, High tcpO2)

D (High TBI, High tcpO2)
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Figure 7.1 TBI & tcpO2 scatter graph

Graph details:
The two axes were marked as follows;
Centre horizontal axis: TBI’s, with the axis intersecting at 0.60 which is the value
classed as a normal outcome for a TBI result (Cole, Norris and Walker. 2000).
Centre vertical axis: tcpO2, with the axis intersecting at 40mmHg which is the marker
above which spontaneous wound healing is likely in normal patients (Sheffield P.J.
2004).
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Plot area or quadrant A (Low TBI and Low tcpO2 group) are the results from both
tests that were below the normal threshold i.e. the TBI was < 0.6 and tcp02 was <
40mmHg. Results from the tests that fell into this quadrant were both below the normal
values and classed as abnormal. 39% of all tests fall into this quadrant.

Plot area or quadrant D (High TBI and High tcpO2 group) are the results from both
tests that were above the normal threshold i.e. the TBI was > 0.6 and tcpO2 was >
40mmHg. Results from the tests that fell into this quadrant were both above the normal
values and classed as normal. 24% of all tests fall into this quadrant.

Plot area or quadrant B (Low TBI and High tcpO2 group) are the results from both
tests were the TBI result is low (<0.6) but the tcpO2 result is above the normal threshold
(> 40mmHg). Results from the tests that fell into this quadrant have one test with
normal values and the other with abnormal values. 31% of all tests fall into this
quadrant.

Plot area or quadrant C (High TBI and Low tcpO2 group) are the results from both
tests were the TBI result is high (>0.6) but the tcpO2 result is below the normal threshold
(< 40mmHg). Results from the tests that fell into this quadrant have one test with
normal values and the other with abnormal values. 6% of all tests fall into this quadrant.
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All four quadrants have been statistically compared to the overall population of results
using a One Sample Proportion T-Test. A P-value less than 0.05 was considered
significant. These tests were performed using Microsoft excel 2013.
The results from these were as follows:

A or Low TBI and Low tcpO2 group


There are significantly more tests with ulcers in the low TBI and low tcpO2
group compared to overall tests (P-value 0.00073). A total of 87.5% of tests in
this group have an ulcer compared to overall tests of 73.5% with ulcers.



There are significantly more tests with hypertension in the low TBI and low
tcpO2 group compared to overall tests (P-value 0.0069). A total of 85.8% of tests
in this group have hypertension compared to overall tests of 76.7% with
hypertension.



Of note there was no statistically significant difference in the proportion of nonsmoker tests present in the low TBI and low tcpO2 group compared to the overall
tests (P-value 0.078) but it was noted to be borderline. There were only 27.5%
non-smokers in this group compared to the overall total of 34.8%.

B or Low TBI and High tcpO2 group


There are significantly more tests on statin therapy in the low TBI and high
tcpO2 group compared to overall tests (P-value 0.0452). A total of 77.3% of
patients are taking statin therapy in this group compared with the overall total
of 69.3%.



Of note there was no statistically significant difference in the proportion of exsmokers (P-value 0.0531) or non-smokers (P-value 0.0921) present in the low
TBI and high tcpO2 group compared to the overall tests, but it was noted to be
borderline. There were 49.5% ex-smokers in the group with overall total at
40.3% and 27.8% of non-smokers in the group with the overall total at 34.8%.
There were slightly less smokers in this group – actual 22.7% versus overall
total of 24.8%.
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C or High TBI and Low tcpO2 group


There were no statistically noted differences in any areas in this group.



Of note there was no statistically significant difference in the proportion of ulcer
tests present in the high TBI and low tcpO2 group compared to the overall tests
(P-value 0.083) but it was noted to be borderline. There were 80% ulcer tests in
this group compared to the overall total of 73.5%.

Overall it is important to note that the numbers in this groups are very small.

D or High TBI and High tcpO2 group


There are significantly more tests who are non-smokers in the high TBI and
high tcpO2 group compared to overall tests (P-value 0.0000006). A total of
56.2% of tests in this group are non-smokers compared to overall tests of 34.8%.



There are significantly less tests who are ex-smokers in the high TBI and high
tcpO2 group compared to overall tests (P-value 0.000014). A total of 24.7% of
tests in this group are ex-smokers compared to overall tests of 40.3%.



There are significantly less tests who have ulcers in the high TBI and high tcpO2
group compared to overall tests (P-value 0.00000022). A total of 53.4% of tests
in this group have ulcers when compared to overall tests of 73.5%.



There are significantly less tests who have hypertension in the high TBI and
high tcpO2 group compared to overall tests (P-value 0.00000044). A total of
57.5% of tests in this group are medicating for hypertension compared to overall
tests of 76.73%.



There are significantly less tests who are on statin therapy in the high TBI and
high tcpO2 group compared to overall tests (P-value 0.012). A total of 57.5% of
tests in this group are medicating with statins compared to overall tests of
69.3%.



There are significantly more tests who are female in the high TBI and high tcpO2
group compared to overall tests (P-value 0.0413). A total of 43.8% of tests in
this group are female compared to overall tests of 34.2%.
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7.4

Discussion

Correlation Coefficient
A positive correlation is when the correlation coefficient is greater than 0 with a +1
signifying a perfect positive relationship. This simply means that both variables move
in the same direction. It indicates a direct relationship, which means, that as one variable
increases the other variable also increases.
Likewise, a 0 indicates no correlation, with a -1 indicating a perfect negative
correlation.

The correlation coefficient between the tcpO2 and TBI tests was 0.49. While this is not
a perfect correlation it is indeed a positive one. When using either the TBI index or the
ATP, both correlation coefficients equated to 0.49. This suggested there was no
difference in diagnosis related to the type of perfusion measurement used, TBI or ATP.

Of interest and as stated earlier these tests measure two different functions and can be
concluded to perhaps offer different degrees of diagnostic information to the clinician.
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Scatter graph:
This diagram, table 7.2, is a summary as per quadrant of the statistical analysis
outcomes detailed in the results section of this chapter.

↑statins

B (Low TBI, High tcpO2)

↓Ulcers
↓Hypertension & statins
↓Ex-smokers
↑Female
↑Non-smokers
D (High TBI, High tcpO2)

↑Ulcers
↑Hypertension
A (Low TBI, Low tcpO2)

C (High TBI, Low tcpO2)

Figure 7.2 Summary of statistical analysis per quadrant
Quadrant A (low TBI and low tcpO2 group) and D (high TBI and high tcpO2 group)
account for a combined total of 63% of all test results. Both test results in each quadrant
have the same outcome i.e. both with a normal result or both with an abnormal result.
One test offers no different information to the other. These are classed as concordant
tests.

Quadrant B (low TBI and high tcpO2 group) and C (high TBI and low tcpO2 group)
account for a combined total of 37% of test results and have two different results i.e.
opposite outcomes. One test result is normal and the other abnormal. These are classed
as discordant tests and are of most interest because of their discordance. Quadrant B
(low TBI and high tcpO2 group) accounts for 31% of tests while quadrant C (high TBI
and low tcpO2 group) represents only 6% of all tests.
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To assist in the discussion of graph analysis, each of the quadrants are detailed in the
table below showing the actual percentage of tests in each quadrant and the breakdown
of the associated risk factors. The overall percentage outcomes for the entire test group
are also shown in table 7.2 for means of comparison.

Male
Female
Smokers
Ex-Smokers
Non-Smokers
Ulcers
Non-Ulcers
HTN
No HTN
On Statin
Not on statin
DM
No DM
T1
T2
TBI
tcpO2

A (LL)
71
29
30
42
28
88
12
86
14
71
29
68
32
17
83
0.21
20

B (LH)
68
32
23
49
28
70
30
82
18
77
23
70
30
22
78
0.34
53

Table 7.1 Actual % outcomes per group

C (HL)
60
40
25
40
35
80
20
70
30
65
35
65
35
8
92
0.78
29

D (HH)
56
44
19
25
56
53
47
58
42
58
42
56
44
15
85
0.81
56

Male
Female
Smokers
Ex-Smokers
Non-Smokers
Ulcers
Non-Ulcers
HTN
No HTN
On statin
Not on statin
DM
No DM
T1
T2

66
34
25
40
35
74
26
77
23
69
31
66
34
18
82

Table 7.2 Overall results
population % outcomes

Graph analysis will be divided into two groups, a concordant group where the tests
results have the same outcome and a discordant group where the tests have opposite
results.
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7.4.1 Concordant tests
Low TBI & Low tcpO2 group (A) – (120 tests or 106 patients - 14 had bilateral tests)
Statistical analysis has shown a significantly higher number of ulcerations in this group.
Of all tests in the study where both outcomes are abnormal (i.e. this group), 88% of
them presented with ulceration. An abnormal result was diagnosed when the TBI result
was less than 0.6 and a tcpO2 value was less than 40mmHg. Patients have a higher risk
of developing ulceration with both a low TBI and low tcpO2. This often results in the
healing of an ulceration being very difficult as both the perfusion and oxygenation of
the tissue are compromised. In this case spontaneous healing is difficult and
intervention is often required. In this group there were a total of 66 interventions on 61
patients. When broken down there were 38 angioplasty procedures (on 33 patients - 3
patients had bilateral angioplasty’s with 2 having 2 redo’s), 27 bypass procedures (on
25 patients - 2 patients had bilateral grafts) and 1 common femoral endarterectomy.
Amputations can often be a likely final outcome. Within this group there were 48 toe
amputation procedures (on 46 patients – 2 patients had 2 toes amputated), 20 TMA’s
(transmetarsal amputations - on 20 patients) with 13 of these having had a preceding
toe amputation. There were 12 BKA’s (below knee amputation on 12 patients) with 6
having a previous TMA and 4 a previous toe amputation. There was 5 AKA’s (above
knee amputation on 5 patients) with one having a previous TMA and 2 having previous
toe amputations. These are a difficult cohort to manage and often have a very complex
medical history.

Statistical analysis has also shown a significantly higher rate of tests medicating for
hypertension in this low TBI and low tcpO2 group which is probably likely due to
individual medical history and overall risk of disease.

High TBI & High tcpO2 group (D) (73 tests or 55 patients -18 had bilateral tests)
Conversely to group A, statistical analysis has shown a significantly lower number of
ulcerations in this group. Of all tests in the study where both outcomes are normal (i.e.
this group) only 53% of them had an ulceration. Both perfusion and oxygenation of
tissue is above normal standards in these tests hence reducing the risk of ulceration.
Even though ulceration is present despite normal test results, there are other reasons
why patients develop ulcers (discussed in chapter 2) such as venous disease,
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neuropathy, infection of a wound and foot deformities. With both tests having normal
results these patients are more likely to heal their ulcers without interventions and less
likely to require amputation. In this group there were no revascularisation interventions.
There were 4 amputations, with 2 (2 patients) toe amputation procedures due to
osteomyelitis and 1 TMA also due to the same reason. There was 1 BKA due to a
Charcot foot with an associated non-healing ulcer in the presence of adequate perfusion.
Of note osteomyelitis is an infection which is treated firstly with antibiotics and if this
fails requires amputation of the infected area

Statistical analysis did show less tests who were ex-smokers in this group but it also
showed significantly more tests who were non-smokers. We know smoking affects
peripheral circulation and has a damaging effect on both the arteries and tissue
oxygenation, so it is understandable this group has been subjected to less of the damage
smoking causes. There were 56% of tests classed as non-smokers in high TBI and high
tcpO2 group versus 28% in the low TBI and low tcpO2 group, 28% in the Low TBI and
high tcpO2 group and 35% in the high TBI and low tcpO2 group.
Statistical analysis has also shown a significantly lower rate of tests medicating for
hypertension and on statin therapy in this high TBI and high tcpO2 group, which is
probably likely due to medical history and their overall risk of disease as was seen in
the low TBI and low tcpO2 group.

Of note and which was not deemed statistically significant it can be seen that there were
less diabetics in the high TBI and high tcpO2 group than in the low TBI and low tcpO2
group, and indeed any other group. There were 56% of test diabetics in the high TBI
and high tcpO2 group versus 68% in the low TBI and low tcpO2 group, 70% in the low
TBI and high tcpO2 group and 65% in the high TBI and low tcpO2 group.

In these groups both tests have similar outcomes and provide no additional information
to aid in the treatment of patients. Perhaps if anything with tests that are just borderline
normal or abnormal, perhaps if the other test result is not borderline it may encourage
further diagnostic investigation.

73

7.4.2 Discordant tests
High TBI & Low tcpO2 group (C) (20 tests or 20 patients)
In comparison to other groups, the statistical analysis of the tests in this group has
shown no significant differences with regards risk factors or ulcer numbers.

Group C with a high TBI and a low tcpO2 result accounts for just 6% of the tests in the
study. When this group was further analysed the average TBI was 0.78 with an average
ATP of 126mmHg. The average tcpO2 baseline was 29 mmHg which increased to 58
post 10 minutes O2 as per the protocol described in chapter 5.3.1. There were noted to
be no interventions in this group.

There are two points to be considered here:
1) falsely elevated digital pressures due to calcification. Digital arteries can become
incompressible due to medial sclerosis or calcification. Within this group there were 6
tests which had a digital x-ray and were reported as having vascular calcification, but
the overall number of patients with digital x-rays is inadequate to be quantified and to
draw any conclusion. Further research in this area is required.
2) falsely depressed tcpO2 must also be considered. This can be attributed to a number
of factors including soft tissue infection, oedema, venous hypertension, steroids, other
immunosuppressants or inadequate nutrition (Fife et al. 2009).
Of note there were 6 patients who had osteomyelitis with 5 of these requiring a toe or
toes to be amputated and one resulting in a BKA. Although the baseline is low the
response to the inhaled 100% O2 was good, which suggests that perhaps many of these
patients are not as ischaemic as their baseline values might suggest. Further study in
this area should be considered. Perhaps a centrally placed truncal sensor measurement
would be helpful in further investigating this.
Low TBI & High tcpO2 group (B) (97 tests or 82 patients – 15 had bilateral tests)
This discordant group with its low TBI and high tcpO2 results account for 31% of all
tests in the study.
When statistical analysis was carried out on this group, the number of tests on statin
therapy (77%), was significantly statistically higher than in comparison to the other
groups and also higher than the overall number of tests (69%). It was shown in chapter
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3, section 6.3.3 that there is a significant difference in ATP in those on statin therapy
versus those not, with there being no difference in tcpO2 results between those on statins
versus those not. ATP’s are lower in the test group on statin therapy. Although not
significantly relevant it was noted that the number of tests medicating for hypertension
in this group was also 5% higher than the overall number of tests. It was also shown in
chapter 3, section 6.3.2 that there is a significant difference in ATP’s in those on
antihypertensives versus those not. Likewise, those on antihypertensives had reduced
ATP’s. This finding concurs with the groups with low TBI’s, which have large numbers
of tests medicating for either hypertension and/or taking a statin and vice versa in the
groups where the TBI’s are normal, the number of tests medicating for hypertension
and/or taking a statin are reduced.

The number of ulcers in this group stands at 70% giving it a lower number of actual
ulcers by 4% than the overall number of ulcers. The number of diabetics in this group
also stands at 70% which is 4% higher than the overall number (22% of these diagnosed
as Type 1 which is 4% higher than the overall number). In general all diabetic patients
tend to be medicated tightly in a bid to reduce the negative impacts it can have on the
body.

The average TBI result in this group was 0.34 with 0.6 considered a normal outcome.
There were 11 (97 in total in the group) tests that were borderline abnormal, with the
results between 0.6 and 0.55. Fifty two tests were above the average TBI of 0.34, with
45 below the average of 0.34.
The average ATP was 55mmHg with the average tcpO2 at 53mmHg.
There were 11 interventions in total which divided into 6 angioplasty’s on 6 patients
and 5 bypass grafts on 5 patients.
There were 21 toe amputations on 21 patients. There were 7 TMA’s with one patient
having bilateral TMA’s. Within these 6 TMA patients, 4 had a previous toe amputation.
There were 6 BKA’s on 6 patients with 4 AKA’s on 4 patients (one of these being a
revised BKA due to infection).
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Flow chart 7.1 shows the numbers of tests with a TBI < 0.6, which is divided into two
groups - tcpO2 < 40 and tcpO2 > 40. These are subdivided into interventions and
amputations.

Flow chart 7: Tests with a TBI < 0.6

In summary the numbers in group B (low TBI and high tcpO2) regarding interventions
and amputations are relatively large in comparison with the other groups C & D. (See
table 7.3 below)

Group
Overall test numbers
Interventions
Toe/s amputated
TMA's
BKA's
AKA's

A
(LL)
120
66
48
20
12
5

B
(LH)
97
11
21
7
6
4

C
(HL)
20
0
5
0
1
0

D
(HH)
73
0
2
1
1
0

Table 7.3 Intervention/amputation numbers of tests across all the groups

This table 7.3, looks at numbers of tests with regards to interventions and amputations.
In some cases one or more interventions or amputations can be attributed to one patient;
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for example a patient may have had an angioplasty or bypass graft and gone on to lose
one toe or more which may have then ended in a TMA or BKA.

Groups C (High TBI & low tcpO2) & D (High TBI & high tcpO2) fair best with no
interventions and small numbers of amputations, although the overall number of tests
in group C are quite low.
Group A, which has low results in both tests, has the largest numbers of both
interventions and amputations and also the largest number of actual tests in the study.
Group B which also has a low TBI result, but, has a high tcpO2 result, is noted to be the
second largest group in the study. This group has a very obvious lower number of
interventions and amputations.

In conclusion the low TBI and high tcpO2 or group B is of particular interest because
of its discordant tests and of the numbers of tests that fall into it. It suggests that in this
patient cohort both tests are important in their own right. This group although it has a
significant incidence of arterial disease and has required a number of interventions, the
proportions of these are significantly lower when compared to the low TBI low tcpO2
group. This would indicate that even in the presence of proven arterial disease i.e.
reduced TBI’s, that if the tcpO2 result is > 40mmHg that intervention does not need to
be the first treatment choice. Traditionally in the setting of ulceration with critical
ischaemia, reconstructive surgery or even amputation has been required. Now with the
emergence of tcpO2 and with its evolving recognition as a valuable diagnostic tool,
perhaps a “wait and see” approach can be taken. This low cost test can lead to a
reduction in the need for expensive imaging tests and even some primary interventions,
resulting in an overall reduction in the financial burden of this cohort on an acute
primary care facility. This study has proven that tcpO2 is a valuable and complimentary
test to the traditional TBI’s in ulcerated patients. Of note, more importantly, in a setting
were TBI’s can’t be performed due to amputation or ulceration of the hallux, tcpO2
should be considered as the alternative first choice test.

The next chapter focuses specifically on the ulcer patients and details the outcomes in
relation to these test results.
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Chapter 8

Examination of factors affecting ulcer
outcomes
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Examination of factors affecting ulcer outcomes

8.1
Aim
As this tcpO2 test was introduced to explore the diagnostic options for patients attending
the diabetic foot protection clinic, further analysis of data focused on all tests performed
on patients who had an active foot ulceration and more specifically those who were
diagnosed as diabetic.

8.2
Method
Statistical analysis of all tests in the 3 year period was undertaken and included
student’s t tests which was used to determine if two sets of data are significantly
different from each other. The tests were evaluated at a 95% significance level (p-value
< 0.05). These tests were performed using Microsoft excel 2013. Further analysis of
data in the chapter used the Fishers exact test. This tests is used to examine the
significance of the association (contingency) between the two kinds of classification of
data and is more appropriate when sample sizes are small.

8.3
Results
There were 310 tests analysed in which 228 were performed on ulcerated limbs and 82
on limbs without ulceration. The tests labelled as non ulcerated tests were taken from
patients who had an ulcer on the contralateral limb.
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Figure 8.1 below, shows the breakdown of the risk factors in the ulcer versus the nonulcer groups. There were more smokers in the ulcer group, 27% versus 19% in the nonulcer group. There were 83% of the ulcer group medicating for hypertension versus
62% in the non-ulcer group. There were 72% of the ulcer group on statin therapy versus
64% in the non-ulcer group. Finally there were 74% of the ulcer group that were
diabetic versus 42% in the non-ulcer group.

Percentage risk factors in the ulcer versus the non-ulcer test groups
100
90
80
70
60
Non Ulcers

50

Ulcers
40
30
20
10
0
Smokers

Hypertensive

Statin therapy

Diabetic

Figure 8.1 Comparisons of risk factors in the ulcer V’s non-ulcer tests
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8.3.1 Analysis of tcpO2 and ATP’s in the ulcer and non-ulcer patients
The following chart shows the results when the two tests were compared in patients
with an ulcer present versus those with no ulcer.
Test
Ulcer
No ulcer
P-Value
Outcome

tcpO2(mmHg)
37
47
p = 0.00014
Indicated difference

ATP (mmHg)
63
81
p = 0.005
Indicated difference

Table 8.1 tcpO2 and ATP’s in the ulcer and non-ulceration group

Mean (± SD) tcpO2 between tests with ulceration and those with no ulceration were as
follows:
Those with ulceration 37 ± 20 mmHg and those with no ulceration 47 ± 17 mmHg.
There was an indicated difference (p = 0.00014) between the mean tcpO2 in the tests
with ulceration and those without.

Mean (± SD) absolute toe pressures between tests with ulceration and those with no
ulceration were as follows:
Those with ulceration 63 ± 49 mmHg and those with no ulceration 81 ± 47 mmHg.
There was an indicated difference (p = 0.005) between the mean absolute toe pressures
in the tests with ulceration and those without.
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8.3.2 Analysis of patients with ulceration – Diabetic V’s non-diabetic patients and
if tcpO2 is significant

Of the total 228 ulcer tests, 170 (75%) of these were diabetics. There were 82% of these
diagnosed as Type 2 and 18% as Type 1. The non-diabetic group were patients who
were classified as not having diabetes at the time of presentation.

Test
Diabetic
Non diabetic
P-Value
Outcome

tcpO2(mmHg)
39
32
p = 0.04
Indicated difference

ATP (mmHg)
66
55
p = 0.16
No indicated difference

Table 8.2 tcpO2 and ATP’s in tests with ulceration in both the diabetic and nondiabetic group.

Mean (± SD) tcpO2 in ulcer tests that were diabetic and those that were not were as
follows:
Ulcer tests in the diabetic group 39 ± 20 mmHg and those ulcers that were not diabetic
32 ± 19 mmHg.
There was an indicated difference (p = 0.04) in the mean tcpO2 between the diabetic
and non-diabetic patient tests in the ulcer group.

Mean (± SD) absolute toe pressures in ulcer tests that were diabetic and those that were
not were as follows:
Ulcer tests on those that were diabetic 66 ± 49 mmHg and those ulcers that were not
diabetic 55 ± 49 mmHg.
There was no indicated difference (p = 0.16) between the mean absolute toe pressures
in the ulcer group between the diabetic and non-diabetic patient.
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8.3.3 Analysis of diabetic tests with ulceration – Type 1 V’s Type 2 tests

Test
Type 1
Type 2
P-Value
Outcome

tcpO2(mmHg)
40
38
p = 0.84
No indicated difference

ATP (mmHg)
61
67
p = 0.39
No indicated difference

Table 8.3 tcpO2 and ATP’s in the type 1 versus type 2 diabetics

Mean (± SD) tcpO2 in ulcer tests who were Type 1 diabetic and those who were Type
2 diabetic were as follows:
tcpO2 on ulcer tests with Type 1 diabetics 40 ± 19 mmHg and those ulcers who were
Type 2 diabetic 38 ± 21 mmHg.
There was no indicated difference (p = 0.84) between the mean tcpO2 in the ulcer Type
1 diabetic and ulcer Type 2 diabetic patient tests.

Mean (± SD) absolute toe pressures in ulcer tests who were Type 1 diabetic and those
who were Type 2 diabetic were as follows:
Absolute toe pressures on ulcer tests with Type 1 diabetes 61 ± 48 mmHg and those
ulcers who were Type 2 diabetic 67 ± 49 mmHg.
There was no indicated difference (p = 0.39) between the mean absolute toe pressures
in the ulcer Type 1 diabetic and ulcer Type 2 diabetic patient tests.
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8.4

Ulceration outcomes

The final analysis was focused on the smaller subgroup of patients with diabetes and
active foot ulceration in an attempt to identify the potential utility of tcpO2 in (1)
determining the likelihood that an ulcer will heal without the need for revascularisation;
(2) in identifying those patients who are likely to require operative revascularisation
and (3) identifying the success or otherwise of a vascular intervention in altering tissue
oxygenation levels. The flow chart below details the breakdown of test numbers.

Flow Chart 8: Breakdown of tests

The total patient population of 170 with diabetes and foot ulceration were followed in
the clinic during the period of the study. The outcome of each ulcer at the conclusion
of the study was categorised into two groups as below:
1) those who had no revascularisation interventions such as an angioplasty,
endarterectomy or bypass procedures
2) those who had some form of intervention carried out.

Each of the groups were further broken down into two distinct categories. These
categories were determined as per a review of the patients chart post an outpatient
appointment during treatment or follow up of their ulceration. These were as follows:
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Healed – skin closed over and ulcer completely healed



Non – healed – no significant improvement noted in ulcer size/area and ongoing
ulcer dressings required +/- a vascular intervention. For the purposes of
analysis, these were treated as non-healed as the final outcome could not be
determined.

The following two sub-sections will analyse the tests separately with regards those
which had an intervention and those which didn’t.
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8.4.1 Non intervention tests
Of the 170 diabetic ulcer tests, 124 had no interventions within the time line of the study
and these were evaluated and monitored until the end of the treatment period with
regards to their treatment/outcome.
Two analyses were performed comparing the healing/non-healing groups using tcpO2
and absolute toe pressures (ATP’s). Based on the literature, a cut off of 30mmHg was
used for ATP’s and 40mmHg for tcpO2. Using Fishers exact test (which is better for
small numbers) the following tables illustrates the tcpO2 and ATP baselines in the
patient cohort with diabetic foot ulcers (DFU).The tests were evaluated at a 95%
significance level (p-value < 0.05).

Table 8.4 below compares absolute toe pressures to healed / non healed outcomes using
a threshold of 30mmHg.
ATP's
HEALED
NON HEALED

>30
73
34

<30
12
5

TOTAL
85
39
124

Table 8.4 Analysis of ATP’s: Healed V’s Non healed outcomes

ATP's : Healed V Non healed outcomes
100%
90%
80%
70%
60%
50%
40%
30%
20%
10%
0%
>30

<30
HEALED

NON HEALED

Figure 8.2 Comparisons of ATP’s: Healed V Non healed outcomes
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A Fishers exact test was performed to compare expected outcome and actual outcome
in this test group. There was no significant difference (p = 0.84) in the ATP threshold
of 30mmHg to indicate healed / non healed outcomes.

Table 8.5 below compares the tcpO2 values to healed / non healed outcomes using a
threshold of 40mmHg.
TCPO2

>40

<40

TOTAL

HEALED
NON HEALED

53
18

32
21

85
39
124

Table 8.5 Analysis of tcpO2: Healed V’s Non healed outcomes

tcpO2 : Healed V Non healed outcomes
100%
90%
80%
70%
60%
50%
40%
30%
20%
10%
0%
>40

<40
HEALED

NON HEALED

Figure 8.3 Comparisons of tcpO2: Healed V Non healed outcomes
A Fishers exact test was performed to compare expected outcome and actual outcome
in this test group. There was no significant difference (p = 0.11) in the tcpO2 threshold
of 40mmHg to indicate healed / non healed outcomes
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It was decided to investigate if using a different tcpO2 cut off value to the literature
(40mmHg) would provide more diagnostic discrimination. The tcpO2 test results
were analysed at 35mmHg, 30mmHg, 25mmHg and 20mmHg with the threshold
value of 30mmHg being the only value to be significantly statistically different.

Table 8.6 below compares tcpO2 to healed / non healed outcomes
TCPO2
HEALED
NON HEALED

>30
69
25

<30
16
14

TOTAL
85
39
124

Table 8.6 Analysis of tcpO2: Healed V’s Non healed outcomes

tcpO2 : Healed V Non healed outcomes
100%
90%
80%
70%
60%
50%
40%
30%
20%
10%
0%
>30

<30
HEALED

NON HEALED

Figure 8.4 Comparisons of tcpO2: Healed V Non healed outcomes
A Fishers exact test was performed to compare expected outcome and actual outcome
in this test group. There was a significant difference (p = 0.04) in the tcpO2 threshold
of 30mmHg to indicate healed / non healed outcomes.
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In further evaluating the significance of the reduction in tcpO2 to 30mmHg, and to aid
in the predication of outcomes, the sensitivity / specificity of the two tests were
analysed. A tcpO2 threshold of 30mmHg was used with an ATP threshold of 30mmHg
also used.
The following table 8.7 details the breakdown of the tests for this analysis.

tcpO2

ATP

<30
Positive test
>30
Negative test
< 30
Positive test
>30
Negative test

Non Healed
Disease present
(Ischaemia)
14 (a)

Healed
Disease absent
(No Ischaemia)
16 (c)

25 (b)

69 (d)

5 (a)

12 (c)

34 (b)

73 (d)

Table 8.7 Analyses of healed Vs non healed test numbers
For the purposes of analysis, a test was deemed to be "positive" if the pressure was <
30mmHg i.e. low pressure = ischaemia = expected non-healing. A test was deemed to
be “negative” if the pressures was >30mmHg i.e. high pressure = not ischaemic =
expected healing.

Test

tcpO2
ATP

Positive Predictive Value
(PPV)
a
a+c
46.67%

Negative Predictive Value
(NPV)
d
b+d
73.40%

29.41%

68.22%

Table 8.8 Predictive values table (For a, b, c & d values refer to table 8.7 above)
Based on the breakdown of test numbers (124 diabetic ulcer tests), a test showing a
tcpO2 of greater than 30mmHg was deemed a "negative test" for ischaemia and
indicated a 73% chance that the ulcer will heal (NPV). Conversely, a value of less than

89

30mmHg (a "positive test" for ischaemia indicated a 46% chance that the ulcer will fail
to heal (NPV).
Likewise with the ATP tests, a test greater than 30mmHg was deemed a “negative test”
and less that 30mmHg was deemed a “positive test”. Both the negative (68%) and
positive (29%) predictive values are lower in the ATP’s when compared to tcpO2.
The analysis of the data from Table 8.6 shows that a tcpO2 level of 30mmHg is
statistically significantly associated with subsequent healing/non-healing of ulcers (p =
0.04). A tcpO2 of <30mmHg is associated with ulcer non-healing in 46% of cases. From
this data tcpO2 was a more accurate indicator of healing rather than ATP’s, which had
a non-healing predictive value of 29%.
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8.4.2 Intervention tests
A large majority of diabetic foot ulcers are superficial and related primarily to
neuropathy. These are managed by offloading and often do not require any vascular
intervention.
Those that are ischaemic or neuroischaemic who may benefit from intervention were
identified by clinical assessment (depth of ulcer, measures of osteomyelitis, pain, extent
of tissue loss, healing response to offloading), measures of perfusion (tcpO2, TBI),
consideration of comorbidities and fitness for surgery, previous surgical history and
known extent of vascular disease, anatomy of disease based on duplex, CT or
angiogram, and patient preference.
There was no one factor that decided intervention. The decision may also have be
revised/changed over time where, for example, the ulcer failed to respond or got deeper
or more extensive despite therapy.
The group of non-healing patients who had an intervention (46) performed were
analysed. These patients were subsequently followed to determine whether their ulcer
had healed at the conclusion of the observation period. This cohort had pre and post test
data collected using both modalities. Unfortunately a number of patients were excluded
from the data analysis (23) due to a number of reasons – they had been discharged and
not seen prior to leaving the hospital or before the end date of the study and/or they had
a hallux or TMA amputation at the time of intervention meaning a post procedure
TBI/ATP was not possible and they only had a tcpO2 test performed.

The following table looks at the outcomes of the diabetic tests (23 tests) which had a
revascularisation procedure in a bid to aid healing or prevent amputation.

tcpO2
ATP
TBI

HEALED (12)
Pre
Post
29
37
24
36
0.17
0.27

NON HEALED (11)
Pre
Post
23
20
21
22
0.13
0.15

Table 8.9 Average measurements of diabetic ulceration pre and post intervention
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Of the healed ulcers post intervention (12) there was an increase in both test results in
comparison to the non healed interventions. Unfortunately for this study the numbers
were deemed too small for any significant analysis to be performed.

The amputations levels where noted to be significant in this group in comparison to the
non intervention group. The table below 8.10 details the number in each group.

AKA
BKA
TMA
Toe
Total

Non Intervention group
(124)
2
9
20
41
72

Intervention group
(23)
2
3
5
16
26

Table 8.10 Amputation numbers
The percentage of proximal or major amputations in the non intervention group versus
the intervention group are 15% and 19% respectively. Of note in the non intervention
group 3 or 27% of these AKA/BKA’s were due to Charcot foot.
There was a larger incidence of distal or minor amputations in the intervention group
with some having more than one amputation procedure during the treatment period.
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8.5

Discussion

As in previous chapters it is known that smoking has a negative effect on the body, and
affects both the micro and macro circulation, with a significant reduction shown in
tcpO2 and in the TBI test results in smokers. In the ulcer test group 27% of tests were
noted to be smokers. Cessation is extremely important in the ulcer patients.
Student t tests carried out earlier in the chapter on all tests, show that the mean tcpO2
and ATP’s are significantly lower in those with ulceration versus those with no ulcers.
This is understandable as ulceration may result from reduced perfusion and/or
oxygenation to a limb resulting in abnormal test results. Ulceration is a multifactorial
process with nutrient supply to the ulcerated area a key component which can be
measured by either or both the microcirculation (Via ATP’s) and the micro circulation
(Via tcpO2).
Further analysis in the chapter focused specifically on the ulcer test group only (section
8.3.2), and on the diabetic tests versus the non-diabetic tests – 75% of ulcers were
diabetics. There was an indicated difference in the tcpO2 in the diabetics versus the nondiabetics. There was no indicated difference in the ATP’s in the diabetics versus the
non-diabetics. Can it be suggested that tcpO2 in the ulcerated diabetics offers alternative
information? It is evident that although PAD is present in both the ulcerated diabetic
and non-diabetic groups with no statistical difference noted between them, diabetic
ulcers have better micro circulation that non diabetic ulcers. These results suggest that
in the non-diabetic group the ulcers are the result of ischaemia due to their low TBI/ATP
and tcpO2 results, while in the diabetic group there are a greater proportion of
neuropathic ulcers due to their higher TBI/ATP and tcpO2 results. In patients with
diabetes, the presence of neuropathy is also an important risk factor for the development
of ulceration. Neuropathy can and frequently does occur without the presence of
significant ischaemia. In the overall ulcer population – especially among the subset with
diabetes - there may be a substantial number of patients with ulceration whose perfusion
is normal or near normal. These results have shown that tcpO2 can help identify patients
with adequate perfusion in the presence of ulceration and therefore tcpO2 is a valid
alternative test in the absence of being able to perform a TBI/ATP in the diabetic
patient.
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Further statistical analyses focused on the diabetic ulcerations due to the large
proportion of these in the study cohort (124). The main concern with ulceration is
healing, how long it will take, if it will occur and if any interventions will be required.
With regards to tcpO2 measurements and the predication of wound healing outcomes,
the consensus in published literature suggests that cut off values above 40mmHg are
required for adequate wound healing and that those below 40mmHg have uncertain
healing outcomes with a large majority of wounds failing to heal (Sheffield P.J. 2004,
Yang C. et al. 2013). Analysis using 40mmHg in this study showed no significant
difference in healing / non healing outcomes however other values were explored.
This body of work would suggest that tcpO2 with a threshold of 30mmHg is the best
predictor of wound non-healing in this patient cohort. Statistical analysis has shown
that there was a significant difference (p = 0.04) in tcpO2 using the 30mmHg threshold
with regards to healing / non healing outcomes. ATP’s at 30mmHg and tcpO2 at
40mmHg when analysed showed no significant difference in healing outcomes. Further
evaluation of the 30mmHg threshold for tcpO2 showed that tcpO2 is more specific and
sensitive in predicating wound healing versus ATP’s (see figure 8.8 ).

There were 23 tests who had pre and post intervention tests for analysis, but for this
study the numbers were too small for any significant statistical analysis purposes.

In summary this piece of work has illustrated that tcpO2 can assist the treating physician
in the prediction of wound healing and provides valuable information in the ulcerated
patients. Importantly, the use of tcpO2 (even in the presence of PAD) allows for the
identification of a group of patients with adequate skin perfusion but with an active
ulcer, suggesting the presence of an alternative cause. This additional information
provides the attending medical professional with more options in the treatment of these
ulcers i.e. in the presence of PAD, these patients ulcers may heal without
revascularisation intervention. This information is unavailable in the absence of tcpO2.

The tcpO2 test has proven itself as a complimentary and valuable diagnostic test to a
TBI / ATP. Given the complexity of many of the diabetic patients presenting to vascular
clinics in recent times, it has become more difficult to treat ulceration successfully. This
is a complex patient group, many of which are well known to the service. Amputations
can be high in this cohort and in the absence of a hallux to record a TBI/ATP it is
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essential to be able to rely on another testing modality to assess perfusion or ability to
heal wounds. tcpO2 has had a positive impact on their treatment and has proven to be a
very beneficial test.
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Chapter 9

Conclusion and Recommendations
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9.0

Conclusion and Recommendations

Ulcers are very problematic for both the patient and healthcare provider with there
being no one universally accepted test that can predict wound healing. The aim of this
thesis was to audit results of a new test, (tcpO2), that was introduced into the vascular
laboratory service over a three year period.

Chapter 6 compared the risk factors of smoking, diabetes, hypertentsion and the use of
statin therapy on the results of the two tests, TBI’s and the newly introduced tcpO2. The
results from both tests were significantly reduced in smokers, with ATP’s only reduced
in those medicating for hypertension. This audit did not show any differences in the
tcpO2 levels between those on medications (antihypertensive and statins) and those not.
The interaction between tissue oxygenation and the use of antihypertensives and statin
therapies are poorly studied and warrants further investigation.
This study did confirm that smoking is the one single risk factor that has a negative
impact on both tests and as such affects both the micro and macro circulation and those
patients with ulceration should be very strongly advised against its use.

Chapter 7 was a direct comparison between the results of both tests. A correlation
coefficient of 0.49 was achieved, and although not a perfect correlation it is a positive
one. Analysis of the data highlighted one cohort of most interest. This group (31% of
total tests) contained the tests where the TBI’s were reduced or abnormal but where
there was a normal tcpO2. i.e. > 40mmHg. When this group is compared to the other
group with both an abnormal TBI and also an abnormal tcpO2, the number of
interventions and amputations are significantly lower in the former i.e. the group with
the normal tcpO2. This implies that having a normal tcpO2 in the setting of PAD will
lead to a higher level of ulcer healing and a lower incidence of intervention and
amputation. It is therefore valid in these patients to take a “wait and see” approach
rather than perform further immediate diagnostic tests, admissions or interventions.
tcpO2 is a valuable and complimentary test to the traditional TBI. Further investigation
of this group is highly recommended and was outside the scope of this study.

Chapter 8 examined diabetic ulcer healing outcomes. Of note there was a statistical
difference in the tcpO2 tests only, between the diabetic and non diabetic patients. The
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differing aetiology of ulceration in the diabetic and non-diabetic populations is an
important consideration in the treatment of these patients. In the non-diabetes most
ulcers are ischaemic and although some patients may have neuropathy, it is less
common. In those with diabetes a significant number of ulcers are due to neuropathy,
with little or no ischaemic component, so average perfusion values appear better as was
seen in section 8.3.2. A comprehensive assessment of these patients including the
evaluation of and documentation of their neurological status would be very informative,
but in this instance was beyond the scope of the vascular laboratory assessments carried
out and this data was not available for the purpose of this study.
Finally further statistical analysis in the chapter focused on the healing outcomes of the
diabetic ulcers. It can be suggested that a threshold level of 30mmHg is the best
predictor of wound healing /non-healing in this patient cohort. Further evaluation of the
30mmHg threshold for tcpO2 showed that tcpO2 is more specific and sensitive in
predicating wound healing versus ATP’s.

In conclusion this thesis has led to a number of observations:


Smoking is the single risk factor proven to effect both tcpO2 and ATP’s, and
should be strongly advised against in all ulcer patients.



The use of tcpO2 and its comparison to TBI’s, has led to the identification a
previously unknown group of patients, where the TBI result was reduced but
the tcpO2 result was normal. This group had significantly less interventions and
amputations.



Neuropathy is a significant factor when dealing with diabetic patients with
ulceration, which vascular physiologists may not always be aware of the
importance of.



A tcpO2 threshold level of 30mmHg is the best predictor of wound healing in
this diabetic ulcer patient cohort. It can be suggested that tcpO2 is more specific
and sensitive in predicating wound healing versus ATP’s
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Recommendations following this thesis are as follows:


Further detailed analysis of the group with reduced TBI’s and a normal tcpO2
test result is recommended.



Although it is widely recommended that a neurological lower limb assessment
of diabetic ulcer patients on initial presentation should be performed, and that
there should be widespread active multidisciplinary management programmes
in place to focus on education, prevention and early intervention in the diabetic
population, there is a variation in practice across Ireland.



tcpO2 is a valuable and complimentary test to the traditional TBI and should be
a considered test in all patients who present with an ulcer. Given the complexity
of the diabetic patient cohort tcpO2 is an important and beneficial test which
should be performed when deciding on treatment.



Subsequent to the completion of this body of work and resulting indication of
the usefulness of tcpO2 as a valuable test, the laboratory protocol has now
evolved to include a simultaneous trunk tcpO2 measurement. This allows a
systemic factor to be considered via the calculation of an RPI (Regional
Perfusion Index). The ability of this RPI to better predict healing potential is
currently being investigated in Tallaght University Hospital.
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